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Three years' low phosphate (P04), low protein (P) diet in children with
chronic renal failure (CRF). K.F. Jureidini, L. Cobiac, L. Daniels, P.
Henning, R.J. Hogg, T.R. Southwood, M.J. van Renen, R. Vining,
Renal Unit, Adelaide Children's Hospital, North Adelaide, South
Australia 5006. Ten children with CRF who had been on conventional
dietary management for at least two years have been treated with a
strict low P04, Low P diet supplemented by the keto acid analogs of the
essential amino acids and histidine (KA) for a further three years. The
study diet differs from conventional diet (CD) for CRF as below:
Conventional
diet Study diet
Phosphate restriction Nil Intense
Protein 2 g/kg/day 1.1 glkg/day
Keto acid mixture Nil 0.3 g/kg/day
KA is given as sugar coated granules (Ketoperlen-Pfrimmer) or a
palatable orange flavored drink (Sharp Laboratories). On both diets,
they have received appropriate bicarbonate, P04 binding gels and
calcitriol. Energy is maximized with carbohydrate and fat supplements.
Monitoring includes growth, well being, multiple biochemical indices,
bone disease and renal function. After three years, the study diet is well
tolerated. Compared with CD, patients show significantly-improved
growth velocity, serum parathyroid hormone, calcium and phosphate
levels, reduced urea and urea/creatinine ratio and lower bicarbonate
requirements. Serum cholesterol and triglyceride levels have improved.
The rate of fall of GFR has decreased. The study diet improves well
being, most indices are improved, and there is no evidence of delete-
rious effects.
The effect of phosphate restriction (PR) on proteinuria and urinary
prostaglandin E2 (PGE2) excretion in models of experimental chronic
renal disease (CRD). D.C.H. Harris, R. W. Schrier, Department of
Medicine, Westmead Hospital, NSW and University of Colorado
School of Medicine, Denver, Colorado, USA. Dietary PR reduced
proteinuria in rats with remnant kidney and nephrotoxic serum nephri-
tis; the mechanism underlying this effect is unknown. The present
studies, therefore, were designed to examine the effect of PR (achieved
with the phosphate binder DHAAA) on other models of CRD. In
comparison to pairfed controls, PR reduced proteinuria in normal rats
(14.73 1.76 vs. 26.63 4.70 mg/day, wk 2, mean SEM, P < 0.05)
and rats with 5/6 nephrectomy (75.4 17.1 vs. 296.0 28.8, wk6, P<
0.001), streptozotocin-diabetes mellitus and uninephrectomy (5.98
2.43 vs. 34.94 8.58, Wk 3, P <0.01), and adriamycin (276.07 100.11
vs. 566.80 79.40, day 6, P < 0.05), but not puromycin nephrotoxicity
(672.80 31.74 vs. 558.93 37.84, day 11, NS). The rapid reversibility
of the effect in normal rats suggested a haemodynamic basis. The later
possibility was investigated further by micropuncture: PR reduced
glomerular hydrostatic pressure (51.7 0.7 vs. 56.3 0.9mm Hg, P <
0.005) and PGE2 excretion (16.95 2.36 vs. 39.72 7.32, ng/day, P <
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0.02) in uninephrectomized rats with streptozotocin-diabetes mellitus.
Similarly, PGE2 excretion was reduced by PR in normal rats (35.38
2.64 vs. 61.79 6.62, wk 4, P < 0.005) and rats with 5/6 nephrectomy
(10.19 1.61 vs. 27.05 5.90, wk 4, P < 0.02). In conclusion: (1) PR
reduces proteinuria in normal rats and in those models of CRD which
are characterized by glomerular hypertension; (2) the reduction of
glomerular hypertension in diabetic rats suggests a hemodynamic
mechanism for this effect on proteinuria; and (3) the reduction of
glomerular hypertension is associated with and may be mediated by the
inhibition of renal prostaglandin production.
Chronic renal failure (CRF) diet without amino acid (AA) supplements
in progressive renal disease—A controlled trial. R.S. Nanra and Kim
Kelson, Department of Nephrology, Royal Newcastle Hospital, New-
castle, New South Wales. The effect of moderate protein restriction
(0.4—0.6 g/kg with 75% of high biological value protein) without AA
supplements was evaluated in progressive renal disease. Dietary phos-
phate (600—900 mg/day) and sodium (50—80 mmol/day) were also re-
stricted in the diet. Seventeen patients (mean age 57.4 SD 13.9 yrs) with
progressive decline in GFR (32 SD 22 to 18 SD 9 mI/mm) over a mean
follow-up control period of 31.4 SD 17.4 months were given the CRF
diet; angiotensin converting enzyme inhibitors and lipid lowering drugs
were not used. The rate of decline in GFR on the CRF diet was 3.3 SD
3.6 mI/mm/yr over 17.2 SD 4.1 months compared to 5.0 SD 3.5 mI/mini
yr during the control period (P < 0.05). There was a fall in the blood
urea/cr ratio (66 SD 17 to 49 SD 10), body weight (73.0 SD 11.9 to 70.3 SD
11.1 kg), urine sodium excretion (136 SD 44 to 112 SD 44 mmol/day) and
serum cholesterol (7.0 SD 1.5 to 6.2 SD 1.2 mmol/liter) (P <0.01); there
were no significant changes in serum phosphate, triglycerides and
albumin concentrations, mean blood pressure and proteinuria. It is
concluded that restriction of protein, phosphate and sodium in diet
without AA supplementation has a beneficial effect in progressive renal
disease.
Renal function in uninephrectomized human subjects. P.L. Liu, R.
Esher, E.D.M. Gallery, A.Z. Gyory, J.F. Mahony. Departments of
Medicine and Renal Medicine, Royal North Shore Hospital, St. Leon-
ards, New South Wales. The renal function of 29 subjects who had
undergone uninephrectomy (18 transplant donors (TD), 11 renal disease
(RD)) was compared with that of 30 normal subjects (N). Renal function
was assessed by a standard 0ne Day Renal Function Test" protocol
(Gyory et al, J Cliii Pathol 27:382, 1974), which includes assessment of
(i) glomerular filtration rate (GFR) by true endogenous creatinine
clearance, (ii) proximal tubular function by 15 minute phenol-sulfon-
phthalein (PSP) excretion, (iii) urinary concentrating ability in response
to water deprivation plus exogenous vasopressin, (iv) urinary acidifica-
tion (pH, titratable acid, ammonia) in response to an oral acid load.
There were minor differences in 15 minute PSP excretion, urinary
concentrating ability and response to an oral acid load. Both unineph-
rectomized groups had increased numbers of urinary casts (N < 15/mi;
TD range 0—2670, mean 201; RD range 0—1500, mean 151). GFR fell
within the normal range in RD subjects (94 12% normal for age) but
was outside the normal range in the TD subjects (79 15% normal for
age). Time since nephrectomy was significantly (P <0.01) shorter in TD
(range 1—123, mean 41 months) than in RD (range 1.7—312, mean 139
months), and age at nephrectomy was greater (TD 47 10 years. RD 21
737
738 Abstracts
13; P < 0.001). Proteinuria was uncommon in both groups (TD 17%,
RD 27%). The lower GFR in TD may represent failure of hypertrophy
of the remaining kidney in these older subjects. The presence of urinary
casts may also signify the presence of renal disease in a proportion of
the subjects.
Use of a DNA probe in the diagnosis of adult polycystic kidney disease
(APKD). J.A. Savige, V. Patrikios, Priscilla Kincaid-Smith, Depart-
ment of Nephrology,Royal Melbourne Hospital, Parkville, Victoria,
Australia. A 24-year-old woman, whose father and elder sister had adult
polycystic kidney disease asked whether she was affected. An ultra-
sound examination revealed one cyst 2 cm wide in the right kidney and
one of similar size in the left, However these findings did not fulfill
Bear's criteria for a conclusive diagnosis of APKD. Here we describe
the use of a DNA probe that segregates with APKD in 95% of affected
Northern Europeans, to answer that question. The 3' hypervariable
region (3'HVR) lies 8 kilobases 3' to the alpha-globin gene on the short
arm of chromosome 16, and comprises a tandemly-repeated 17 base-
pair core sequence bounded by two Pvull sites (Reeders et al, Nature
317:542, 1985). DNA from this region was used to probe DNA from
individuals under investigation. DNA from peripheral blood leucocytes
from the patient and her family was extracted, digested with the
restriction enzyme PvuII and run in a 1% agarose gel in 2 x TBE at 40v
overnight. The gel was then denatured, blotted in 20 X SSC and
hybridized with the DNA labelled by the nick translation method,
overnight in 50% formamide at 42°C. The filter was then washed in 0.1
x SSC at 60°C and exposed to photographic film at —70°C for 4 days.
This showed that in this family the disease segregated with a 6 kilobase
fragment on Southern blot analysis; and that the patient indeed had
adult polycystic kidney disease.
Fluoroquinolones in patients with polycystic kidney disease (PKD).
W.M. Bennett, T.A. Golper, L. W. Elzinga, Oregon Health Sciences
University, Portland, Oregon, USA. In PKD, infection within cysts is
often refractory to treatment because of poor antibiotic penetration into
cyst fluid. Based on theoretical considerations, lipophilic drugs with
high pka should penetrate both "gradient" and "non-gradient" cysts.
The fluoroquinolones, ciprofloxacin (Cip) and norfioxacin (Nor) have
these properties plus an excellent antimicrobial spectrum versus likely
gram-negative pathogens. Fluid was obtained by cyst aspiration in 7
patients (80 cysts) before and after Cip therapy given in doses adjusted
for renal function. Mean concentration of Cip in cyst fluid was 12.7
3 sg/ml, with a cyst fluid/serum ratio of 2.5. Gradient cysts accumulated
more Cip than non-gradient cysts (P < 0.01). Both types of cyst fluid
sampled during Cip consistently demonstrated high inhibitory and
bacteriocidal titers against E. Co/i and Proteus Mirabilis, equaling or
exceeding 1:32 in all but one cyst. Nor was administered to 5 additional
patients (91 cysts). There was good concentration in gradient cysts 24.0
5 sg/ml but poor concentration in the more plentiful non-gradient
cysts. Furthermore, Nor did not increase bacteriocidal or inhibitory
titers in fluid from non-gradient cysts. Conclusion: Both fluoroquino-
lones achieve good concentrations and killing activity in gradient cysts
in patients with PKD. Cip appears to penetrate non-gradient cysts to a
greater extent than Nor and is the better therapeutic choice on
theoretical grounds for PKD infections.
Experience with triple therapy in 114 cadaveric renal transplants. AC.
Restifo, J.J.B. Petrie, R.J. Righy, I.R. Hardie, J. O'Connor, J.R.
Burke, P.G. Row, R.W. Strong, D.R. Wall, S.V. Lynch, f.M. Quinn,
P. W.H. Woodruff, Renal Transplant Unit, Princess Alexandra Hospi-
tal, Brisbane, Queensland, Australia. Triple therapy (azathioprine [Az]
2 mg/kg/day, cyclosporin A [Cs] 8 mg/kg/day & prednisolone [P1 20 mg/
day was used for 26 second and third grafts (CDK2+3) from 1.10.85(0
30.10.87 and 88 first grafts (CDK I) since 1.8.86. For initial non-function
(INF), Cs was reduced and P increased; high risk patients with INF had
ATGAM and no Cs for 4 days. Cs doses were adjusted to maintain
blood levels (HPLC) of 125—250 ng/ml or 80—ISO ng/ml for INF. CDKI
graft survival was 90 3%at 6 months and 88 5% at 1 year; CDK2+3
survival 83 9% and 77 11%. One year CDKI results in 1983—1986
were 82 5% with Cs alone and 74 7% with Az & P. Cs
nephrotoxicity caused fewer problems with triple therapy than with Cs
alone; viral infections were more frequent, but similar to those with Az
& P. Twelve patients received 14 courses of OKT3 for rejection; of
these, 2 grafts were lost and 1 patient died; all 12 developed viral
infections (II herpes simplex; 5 CMV; I EBV). Six of the 114 patients
(5.3%) died: 2 from ischemic heart disease in week I, I septic shock an
day 2, 1 CMV at 1 month, 1 necrotizing colitis at 2 months and I
lymphoma at 4 months. Triple therapy achieves satisfactory graft
survival and minimum Cs and Az toxicity. It offers greater flexibility but
may cause more viral infections,
Progress and problems with dialysis and transplantation in the aborig-
inal population. D.J. Pugsley, T.H. Mat hew, A.P.S. Disney, G.R. Russ,
J. Hay, Renal Unit, Queen Elizabeth Hospital, Woodville, South
Australia 5011 and Red Cross Tissue Typing Laboratories, Adelaide,
South Australia 5000. Since 1962, 61 Aborigines from The Northern
Territory (44) and South Australia (17) have entered end-stage renal
failure programs, 38 (62%) since 1985. Their ages ranged from 11—61
yrs; 48 (82%) were aged between 30—59 yrs. Fifty percent of the
Aboriginal population are aged less than 25 yrs, but there were only 6
patients in this age group. 1our patients have received CAPD, 5 home
hemodialysis and 16 have had treatment at satellite self care dialysis
centers. Social, geographical and financial problems entail the need for
a considerable staff input to cope with these difficulties. Twenty-nine
patients received transplants; 6 cadaveric grafts were lost due to
rejection and 3 patients died with functioning grafts. Programs in which
kidneys are allocated on the basis of identity at the H LA-B and -DR loci
will offer few kidneys to Aborigines whose antigen pool is both
restricted and very different from that of Caucasian Australians. There-
fore we have sought to obtain kidneys from living relatives (LRD): 10 of
the 19 kidneys transplanted in the last 4 years have been from such
sources. All these LRD grafts are still functioning. Donation of kidneys
in this setting is associated with ethical and social problems which merit
further discussion.
Synchronous pancreas and renal transplantation. JR. Chapman, R.D.
Allen, S. Deane, C. Eastman, J.H. Stewart, f.M. Little. Renal Unit and
Department of Surgery, Westmead Hospital, New South Wales 2145.
Survival of diabetic patients with end-stage renal disease treated either
by hemodialysis or by transplantation is inferior to that of patients with
other causes of renal failure. Development of successful pancreas
transplantation might ameliorate further decline in retinopathy, neurop-
athy and vascular disease, thereby improving the quality of life of
immunosuppressed diabetic recipients of renal allografts. Two diabetic
patients treated with insulin for 20 years each have undergone synchro-
nous pancreas and renal transplantation. The whole pancreas was
transplanted into the right iliac fossa with exocrine drainage to the
bladder, while a kidney from the same donor was placed conventionally
on the left. Both patients were treated for acute renal allograft rejection,
but neither serum or urinary amylase nor C-peptide measurements gave
reliable indication of pancreas rejection. At three months both kidneys
are functioning with GFR measurements of 42 and 54 mI/mm and
creatinine values of 96 and 147 mol/liter. Both patients had normal
fasting glucose at 5.4 and 3.8 mmol/liter. The response to a 75 g oral
glucose load was abnormal in the first patient with a peak glucose of
14.6 mmol/liter at 90 mins with an insulin level of 123 U/ml, suggesting
a degree of peripheral insulin resistance. In the second patient the peak
glucose level of 7.2 mmol/liter was achieved at 30 minutes, returning to
5.0 mmol/liter by 90 mins. Although these transplants have been
technically successful the medium and long-term advantages of the
operation will need careful evaluation.
Effect of recipient treatment with adenosine triphosphate and magne-
sium on renal transplants on the rat. M. Biguzas, P. Jablonski, A.
Thomas, K. Walls, B. Howden, V.C. Marshall, Monash Department of
Surgery, Prince Henry's Hospital, Melbourne, Australia. Adenosine
triphosphate (ATP) concentrations fall in the ischaemic kidney and
treatment of the recipient with ATP/Mg/Cl2 immediately after revascu-
larization may be of value after prolonged cold preservation of the graft.
Such treatment has been shown to be beneficial after warm ischemia
damage of the kidney, heart and liver. All kidney grafts were flushed in
situ and preserved by continuous perfusion with 5% BSA/phosphate
buffer/sucrose (pH 7.1, 300 mOsm/kg) 18 mI/hr at 4°C for 48 hours. The
grafts were transplanted heterotopically. Recipients received an intra-
venous infusion of ATP/MgCI2(25 imol of each, dissolved in saline) for
30 minutes, commencing immediately on revascularization of the graft.
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A control group received an infusion of saline. Nephrectomy of the
recipient's kidney was delayed for 5 days. Survival was similar for both
groups (ATP/MgCI2: 7/8 v; Control: 8/8). Renal function was poor in
both groups; animals were polyuric, GFR was markedly impaired.
However, the treated animals had a significantly (P < 0.02) increased
GFR at all times during the follow-up period (1 month). Polyuria and
loss of sodium were not affected significantly by the treatment. Con-
clusion: ATP/MgCl2 treatment appears to be of some benefit in the
transplantation of the cold-ischemically damaged kidney. Such treat-
ment should be considered if immunosuppression with cyclosporin A is
contemplated.
Pretransplant blood transfusion with concomitant cyclosporin A (CYA)
reduces the rate of sensitization. Graeme R. Russ, G. Bennett, J. Hay.
Renal Unit, Queen Elizabeth Hospital, Woodville SA & Red Cross
Blood Centre, Adelaide, Australia. Pretransplant blood transfusion
(BT) has a beneficial effect on renal allograft survival but leads to the
development of lymphocytotoxic antibodies (LCA) which may jeopar-
dize transplantability. BT with concomitant immunosuppression has
been reported to reduce such sensitization. This study compares the
sensitization rates of dialysis patients transfused with and without CyA
therapy. Dialysis patients who had never had previous BT were
randomly allocated into 2 groups. Group I received between 2 and 4
third party BTs given over a six week period. Group II received the
same BT regime, but each BT was covered with CyA given at a dose of
7.5 mg/kg b.d. on the day before, the day of and the day after BT. Sera
taken before the first BT and between 2 and 4 weeks after the last BT
were screened I) against peripheral blood lymphocytes of a random
panel of 40 to 50 cell donors, and 2) against a panel of HLA-typed cells
to identify specific HLA antibodies. In group I, 2 patients had LCA
before BT (due to pregnancies), and of those without pre-BT LCA (N =
25), 6 developed LCA within one month of the last BT. In group II, 4
were already sensitized pre-BT and none of 23 unsensitized patients
developed LCA. The difference in sensitization rates is statistically
significant (chi square = 6.31, P = 0.0118). Side effects in group II were
nausea/vomiting (5), feeling of dissociation (I), tremor (3) and paraes-
thesia (4). Twelve and 18 patients in groups I and II respectively have
been transplanted. One graft (from a group I patient) has been lost.
Thus, BT with concominant CyA therapy in potential renal allograft
recipients is associated with a reduced rate of sensitization, with no
apparent loss of the beneficial effect of BT. However, the described
regime is associated with a significant incidence of side-effects.
Hypogammaglobulinemia following renal transplantation. C. Pollock,
J. Mahony, R. Caterson, Renal Medicine, Royal North Shore Hospital,
St. Leonards, New South Wales, 2065. Obligatory immunosuppression
associated with renal transplantation results in increased susceptibility
to infection, particularly in the early post-transplant period. We report
5 cases of clinical hypogammaglobulinemia occurring late in renal
transplant recipients. Five females with varying causes of end-stage
renal failure presented with recurrent bacterial infections of the skin,
respiratory and urinary tract, and I had a prolonged post-viral syn-
drome. Patients ages ranged from 33 to 66 years (55.6 13.1, SD)
with time from transplant to follow up 69 to 275 months (173 59.6).
None were diabetic nor had undergone splenectomy. All were initially
immunosuppressed with prednisone, azathioprine, and 4 of 5 received
antilymphocyte or antithymocyte globulin, the remaining patient re-
ceiving actinomycin C. Maintenance therapy in all was azathioprine and
prednisone. All patients had low serum lgG and IgA levels (lgG
undetectable — 6.7 glliter; IgA undetectable — 0.68 gtliter). One patient
had a concomitantly low serum 1gM level. Mean time to diagnosis of
hypogammaglobulinemia from transplantation was 151 57 months
(range 67 to 214). Treatment with intramuscular gammaglobulin
monthly resulted in subjective clinical improvement and objective
decrease in frequency of infection. Two patients with established
chronic rejection lost their grafts and recommenced dialysis at 192 and
207 months and have remained on hemodialysis for 9 and 27 months,
respectively, with no improvement in serum gammaglobulin levels. We
conclude that hypogammaglobulinemia may contribute significantly to
infection in successful graft recipients on long-term immunosuppression
and may be improved by regular gammaglobulin therapy.
Comparison of pregnancy outcome between normotensive and hyper-
tensive women with primary glomerulonephritis. D.K. Packham, K.F.
Fairley, B. U. Jhle, J.A. Whitworth, P. Kincaid-Smith, Department of
Nephrology, Royal Melbourne Hospital, Victoria, Australia. The clin-
ical courses of 105 pregnancies in 76 women with biopsy proven,
primary glomerulonephritis have been reviewed to determine the prog-
nostic implication of pre-existing hypertension. Fetal and maternal
outcome of patients hypertensive (N = 21) and normotensive (N = 55)
prior to pregnancy were compared. Total fetal loss was similar (18% vs.
16%) as was perinatal mortality (6% vs. 7%). Prematurity rates were
also similar (24% vs. 15%) but 25% of infants of hypertensive mothers
were small for gestational age compared with only 4% in normotensives
(P < 0.05). Blood pressure was 90 mm Hg in 47% of hypertensives
despite continuation of prepregnancy anti-hypertensive therapy, com-
pared with 23% in normotensives. Early hypertension was more com-
mon in previously hypertensive patients (28%) than in normotensives
(10%, P < 0.05). Thus pre-existing hypertension was not a major
determinant of fetal outcome in this series of women with primary
glomerulonephritis, although the incidence of small for gestational age
infants and of early pregnancy hypertension was significantly higher if
hypertension predated pregnancy. In the absence of other bad prognos-
tic features, hypertension should not be regarded as a contra-indication
to pregnancy in women with pre-existing nephritis.
Immunoelectronmicroscopy of glomerular lesions using protein-A gold.
M. Nakajima, D. Mathews, Department of Nephrology, Royal Mel-
bourne Hospital, Parkville, 3050, Australia. To establish a precise
correlation between immunologic and morphologic findings, we em-
ployed a postembedding immunogold labeling technique using a pro-
tein-A (PAG) complex as a marker in human renal biopsies. Tissue was
fixed in periodate-lysine-paraformaldehyde (PLP), post-fixed in
Osmium Tetroxide, and embedded in L.R. White resin. Ultrathin
sections, mounted on nickel grids, were etched with either sodium
m-periodate or hydrogen peroxide prior to incubation in the various
antisera. Using the PAG marker, positive results were obtained after
incubating with rabbit anti-human IgG, IgA, 1gM, C3C and fibrinogen,
while control experiments, performed with the omission of the antise-
rum incubation step, proved negative in all cases. The combination of
PLP/OsO4 fixation and etching allowed not only for good preservation
of ultrastructure but also for good immunoreactivity. Intense labeling
was demonstrated in the electron dense deposits specific for the various
types of glomerular diseases. Examples include mesangial IgA in IgA
nephropathy, IgG in membranous nephropathy, 1gM and fibrinogen in
Goodpasture's syndrome and C3C in poststreptococcal glomerulone-
phritis. None of the control sections showed any specific staining. This
postembedding immunogold labeling procedure has a distinct advantage
compared to pre-embedding immunostaining methods using horserad-
ish peroxidase conjugated antibodies because: (a) the technique is very
simple; (b) there is adequate penetration of antibodies in renal tissue; (c)
the gold particles do not "blur" the tissue morphology, especially the
deposits; and (d) it is possible to double-label the same section using
different sizes of gold particles. In conclusion, this technique using the
protein-A gold marker is proposed as a significant tool in the study of
renal pathogenesis.
Is there an alternative to aluminium hydroxide for phosphate control in
hemodialysis patients? K.L. Lynn, A.L. Buttimore, J. Pybus, R.R.
Bailey, Department of Nephrology, Christchurch Hospital, Christ-
church and Department of Clinical Chemistry, Auckland Hospital,
Auckland, New Zealand. Aluminium (Al) toxicity may occur in hemo-
dialysis (HD) patients exposed only to oral Al. We stopped Al-
containing drugs in 37 (21 men) patients aged 45.5 (sD 15.6) yr on home
HD (3 x 8 to 10 hr) for 1 to 111 (median 26) months using plate dialyzers
(1.0 m2) and dialysate containing Al <0.60 smol/liter, calcium (Ca) 1.60
to 1.95 mmol/liter, magnesium (Mg) 0.6 to 0.7 mmol/liter. Al hydroxide
had been taken by 27 (14 men) patients for 2 to Ill (median 17) months:
daily dose 218 to 2052 (median 435) mg, cumulative dose 0.026 to 6.8
(median 0.43) kg of Al. All Al-containing drugs were stopped and over
6 months, CaCO3 or Mg trisilicate were used in an attempt to maintain
the pre-HD plasma phosphate (P) < 2.0 mmol/liter. Plasma Al was
higher in those taking Al (2.03 [SD 1.46] mol/liter, N = 27 vs. 0.49 (SD
0.30], N = 10;P < 0.001) and was positively correlated with cumulative
dose (r = 0.47; P < 0.02). After 6 months, 27 patients had received
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CaCO3 (ito 3 g/day) [7], Mg trisilicate (30 to 60 mI/day) [9], both drugs
[9] or none [21. in addition, 8 patients received calcitriol (0.25 pg/day)
and 4 Al-containing drugs (2 without our prior knowledge). Plasma Al
had fallen from 1.81 (SD 1.55) jimol/liter to 1.18 (SD 0.99) smol/liter.
Pre-HD Ca (2.63 [SD 0.24] vs. 2.67 [SD 0.30] mmol/liter), P (1.94 [SD
0.66] vs. 2.08 [SD 0.551 mmollliter); Hb and alkaline phosphatase were
unchanged. Reversible hypercalcemia occurred in 10 patients (calcitriol
and CaCO3 [3], CaCO3 alone [5], Mg trisilicate [2]. Pre-HD Mg in those
taking Mg trisilicate was 1.73 (SD 0.37) mmol/liter (NR 0.6 to 1.2 mmol/
liter). In summary, Al fell when Al therapy ceased. CaCO3 and/or Mg
trisilicate were similarly effective at controlling P, but raised plasma Ca
and Mg were common.
Decreased atrial natriuretic peptide binding in renal medulla of rats
with chronic heart failure. P.M. Sexton, K. Tsunoda, G.P. Hodsman,
C.!. Johnston, F.A.O. Mendelsohn, Department of Medicine, Austin
Hospital, Heidelberg, Victoria, Australia. The relationships between
atrial natriuretic peptide (ANP) binding Sites in the kidney, plasma ANP
concentration and ventricular dysfunction have been studied in rats 4
weeks after myocardial infarction induced by left coronary artery
ligation. Plasma ANP concentration was measured by radioimmunoas-
say and quantitation of ANP receptors was performed by computerized
in vitro autoradiography using '251-labelled a-rat ANP as the radioli-
gand. Rats with myocardial infarction had markedly elevated plasma
ANP compared to controls (462 82 vs. 124 20 pg/mI, P < 0.01) and
reduced binding densities of ANP in the inner renal medulla (2.93
0.19 vs. 3.53 0.22 fmoi/mg protein, P < 0.01). Competition data
indicated that large myocardial infarction was associated with a de-
crease in receptor number in the inner medulla (33.6 5.7 vs. 95.6
9.6 fmol/mg protein, P < 0.01) with no change in the affinity constant
(1.76 0.51 vs. 1.03 0.15 x l0 M, P> 0.05). Binding densities in
the inner medulla of rats with myocardial infarcts were negatively
correlated with right ventricular weight, plasma ANP and with infarct
size(r =
—0.92, P <0.001; r = —0.78, P <0.001; r = —0.77, P <0.01,
respectively). These results suggest that specific binding sites for ANP
in the inner medulla decrease in proportion to the elevation in circulat-
ing ANP levels, which in turn are related to infarct size and degree of
ventricular dysfunction. Down regulation of renal ANP receptors may
underlie renal resistance to ANP in heart failure and thereby contribute
to sodium chloride and water retention.
Definition of discrete glomerular antigens by monoclonal antibodies
(McAbs) produced against a human glomerular membrane fraction
(IIGMF). T.J. Neale, M. Callus, H. Baird, Department of Medicine,
Wellington School of Medicine, New Zealand. To establish human
relevance for animal models of in Situ glomerulonephritis (GN), we
have sought to define comparable antigen-antibody systems in man,
using hybridoma technology. Mice were immunized with 20 to 100 sg of
HGMF, by intraperitoneal or intrasplenic routes. Six fusions have
yielded 12 stable reagents defined by positive glomerular indirect
immunotluorescence (IF) and microELISA using HGMF as the screen-
ing antigen. Subclass analysis of ascitic McAbs revealed eight IgG,, one
igG2 and three 1gM reagents which have been purified by caprylic acid
or anti-IgM affinity chromatography. Distinctive patterns of reactivity
with epithelial, endothelial or mesangial structures, with or without
peritubular capillary, tubular basement membrane and vessel wall
reactivity, have been observed, Seven normal non-renal human organs
and the kidneys of rat, rabbit and sheep have shown patterns charac-
teristic of each individual McAb, restricted to human or with species
cross reactivity. Striking McAb and diagnosis-specific patterns of
reactivity have been determined on nephritic renal biopsy tissue. To
partially characterize McAb-reactive antigens, detergent-solubilized
HGMF and collagenase-solubilized GBM (CS-GBM) extracts have
been probed by immunoblot. For example, McAb 7-5QC, reactive with
glomerular epithelial structures, binds major bands of approximately
120 and 140 kD, and 5-3AH (a human-restricted linear-reacting McAb)
binds bands of 20 to 200 kD (major band 58 kD) in CS-GBM. In
conclusion, distinct species-restricted and more broadly disposed gb-
merular epitopes are definable in man by McAbs and are potential
targets for humoral injury. Purification of these antigens will allow
assay for circulating putative nephritogenic auto-antibody.
Primary focal and segmental hyalinosis and sclerosis and pregnancy.
D.K. Packham, R.A. North, K.F. Fairley, B.U. Ihie, J.A. Whitworth,
P. Kincaid-Smith, Department of Nephrology, Royal Melbourne Hos-
pital, Victoria, Australia. The thirty-one pregnancies, and post-partum
clinical course, of 21 women with a diagnosis of primary focal and
segmental hyalinosis and sclerosis, have been analyzed to determine
maternal and fetal outcome in this disease. Forty-five percent of
pregnancies resulted in fetal loss, 39% in premature delivery and 16% in
a term infant. Of 17 fetuses for whom birthweight was recorded, 29%
were small for gestational age. Maternal renal function deteriorated in
49% of pregnancies, in 13% irreversibly. Three of these patients
subsequently progressed to end-stage renal failure, and one to progres-
sive chronic renal impairment, during follow-up (median 4 years, range
1 to 25 years). In 74% of pregnancies hypertension was recorded, and
this frequently developed early (61%) and was severe (45%). Nephrotic
range proteinuria developed in 42% of pregnancies. Increased protein-
uria was recorded in 22 (17%) of pregnancies. It is concluded that
pregnancy in women with primary focal and segmental hyalinosis and
sclerosis is associated with increased fetal loss and maternal complica-
tions.
Peritoneal morphology in patients on maintenance dialysis (MD). C.
Pollock, L. Ibels, J. Graham, R. Eckstein, J. Mahony, R. Caterson,
Renal Medicine, Royal North Shore Hospital, St. Leonards, New
South Wales, 2065, Australia. In order to assess the changes in
peritoneal membrane morphology (PMM) in patients on long-term
dialysis, 24 peritoneal biopsies were done in 22 patients. Biopsies were
from patients with normal renal function (N = 4);end-stage renal failure
prior to commencement of MD (N = 4); long-term, continuous ambu-
latory peritoneal dialysis (CAPD; duration 32.3 9.9 months, SD,
N = 10) and long term hemodialysis (HD; duration 74.7 46.3 months,
N = 4). Of those on HD, two had undergone CAPD for short periods at
least 2 years previously. PMM in patients with normal renal function
and those prior to dialysis was similar with normal or partially stripped
mesothelium, loose collagen and no inflammatory infiltrate. One patient
on CAPD with no prior peritonitis had normal PMM. All others on
CAPD had partial or complete mesothelial cell loss, variable inflamma-
tory infiltrate and peritoneal neovascularization. Collagen thickness
(CT) was significantly greater than in normals being 0.336 0.145 vs.
0.132 0.08 mm (P < 0.02). Density of fibers rather than CT was
associated with loss of ultrafiltration. Peritoneal creatinine clearance
was independent of PMM. Frequency of peritonitis showed no consis-
tent association with PMM other than the presence of inflammatory
infiltrate. Of 4 patients on HD, 3 had partial or complete stripping of the
peritoneum with CT (0.32 0.19 mm) and density similar to that seen
in CAPD. Peritoneal foreign bodies were seen in 4 patients; 2 CAPD, I
HD, I CAPD + HD. Amyboid was present in I HD patient. We
conclude that changes in PMM occur in patients on CAPD and may
persist despite transfer to long-term 1-ID or alternatively develop in
patients on either form of MD. Ultrafiltration appears related to
collagen density. No association with PMM and peritoneal clearances
was observed.
Acute cisplatin nephrotoxicity: an electron microprobe analysis. M.J.
Field, T.E. Bostrom, F. Seow, C. Nockolds, A.Z. Gyory, D. Cockayne,
Department of Medicine and EM Unit, University of Sydney, New
South Wales, 2066, Australia. To evaluate the cellular mechanisms
involved in the initial phase of renal injury induced by the chemother-
apeutic agent cisplatin, we performed combination clearance/electron
microprobe studies in Wistar rats. Control rats were infused with
Ringer solution at 2% of body weight/hr after a priming injection of
saline (1% body wt). Cisplatin rats received the drug in a dose of 10 mg/
kg in the saline prime, followed by the drug-free Ringer infusion.
Tritiated inulin was also included in the infused fluids to allow for
estimation of GFR. Between 90 and 150 minutes after the priming
injection, cisplatin-treated animals had a significantly lower GFR than
controls (0,39 0.02 vs. 0.50 0.02 ml/min/iOO g, mean SE, P <
0.005), while their urinary flow rate and fractional Na excretion rate
(0.46 0.04 vs. 0.08 0.01%, P < 0.0001) were significantly higher. At
the conclusion of the clearance collections, the left kidney from each rat
was removed, immediately quench-frozen in liquid propane-isopentane,
and subsequently cryosectioned. Freeze-dried cryosections were ana-
lyzed in the electron microscope using energy-dispersive X-ray micro-
analysis, This demonstrated a lower concentration of Na within indi-
vidual proximal tubular cells in cisplatin-treated kidneys compared to
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controls (18.8 0.7 vs. 22.7 0.7 mmol/kg wet wt, P < 0.0005). When
corrected for cell shrinkage (higher dry weight), after cisplatin, a
significantly lower cell content of both Na (85.1 3.5 vs. 113.9 3.7
mmol/kg dry wt, P < 0.0001) and K (695.9 13.2 vs. 764.2 10.4, P
<0.0001) was observed in the treated kidneys. These findings are best
explained by an effect of cisplatin to impair Na uptake across the
luminal membrane of proximal tubular cells, resulting in natriuresis and
secondary depression of the OFR via the macula densa feedback
mechanism.
Quantitation of glomerular angiotensin II (All) receptors in IgA
nephropathy. G. Hale, G. Howarth, I. Aarons, A. Clarkson, A.
Woodroffe, Renal Unit, Royal Adelaide Hospital, and Division of
Tissue Pathology, Institute of Medical and Veterinary Science, Ade-
laide, South Australia. Mesangial cells have receptors for All and
contract in its presence. All is known to increase the uptake of
macromolecules by the mesangium. As a first step in investigating
possible local disturbances of the renin-angiotensin system in immune
mediated mesangioproliferative glomerulonephritis, glomerular All re-
ceptors have been quantitated retrospectively in biopsy tissue from 20
patients with IgA nephropathy for comparison with 17 biopsies that
showed only minor abnormalities by light microscopy and negative
immunofluorescence. An autoradiographic technique using 1251 labelled
Sar', lie8 angiotensin II facilitated the quantitation of All receptors in
frozen tissue sections. Following exposure to the treated sections, x-ray
film was analyzed by computerized micro-densitometry. The data
obtained were optical densities of areas corresponding to the presence
of glomeruli verified by reference to adjacent sections stained with
hematoxylin and eosin. There was no significant difference between
patients 0.67 0,16 (mean so) and controls 0.61 0.15. Among
patients there was a weakly positive association between glomerular
All receptor density and the degree of mesangial proliferation and a
more marked though not statistically significant correlation with hyper-
plasia of the juxtaglomerular apparatus. There was no apparent rela-
tionship with hypertension. Further prospective studies with careful
control of parameters such as sodium intake and the duration of storage
of biopsy tissue may be necessary to fully elucidate these associations.
Evidence for the participation of cell mediated immunity in the
deposition of fibrin in human glomerulonephritis. T.J. Neale, P.G.
Tipping, P. Sabonadière, P. Carson, S.R. Holdsworth, Dept. of Med-
icine, Wellington School of Medicine, Dept. of Medicine, Prince
Henry's Hospital, Melbourne and Dept. of Hematology, Denver,
Colorado, USA. Fibrin deposition is prominent in delayed type hyper-
sensitivity (DTH) reactions, and in this form of cell-mediated immunity
(CMI) is initiated by antigen-specific, T lymphocyte-directed macro-
phage expression of human tissue factor (HTF). Fibrin deposition in
glomerulonephritis (ON) is also associated with macrophage accumu-
lation, but its pathogenesis is unknown. Moreover, a role for CMI in
human ON is not established. If DTH mechanisms contribute to fibrin
deposition in ON, glomerular fibrin would be expected to be closely
associated with T lymphocytes, and macrophages expressing HTF. To
test this hypothesis, 10 fibrin-positive and 24 fibrin-negative renal
biopsies from patients with a variety of types of ON, and normal
controls, were studied prospectively for these elements of DTH.
Monoclonal antibodies specific for each component were used in
immunoperoxidase microscopy. The anti-HTF reagent is known to
potently inhibit HTF function. All fibrin positive biopsies were from
patients with aggressive (often crescentic) proliferative ON, and all
showed prominent giomerular macrophage accumulation (P < 0.006
compared to fibrin negative biopsies, Wilcoxson rank sum), and intense
glomerular staining for HTF. Weak constitutive staining for HTF was
evident in some normal controls and fibrin negative biopsies. T cells and
their subsets were significantly more evident in fibrin-positive com-
pared to fibrin-negative biopsy glomeruli (P < 0.009 for total T and
CD8; P < 0.01 for CD4). Thus all the essential elements of DTH were
simultaneously demonstrated within glomeruli from patients with fibrin
related ON. These findings suggest a role for CMI in human ON.
Immunocytochemical analysis of peripolar and granulated epithelial
cells using protein A-gold. M. Nakajima, D. Mathews, P. Kincaid-
Smith, Department of Nephrology, Royal Melbourne Hospital, 3050,
Australia. Speculation still surrounds the role of the glomerular pen-
polar cell, and more recently, the granulated epithelial cell. Morpho-
logically the connection between these two cell types is based upon the
observation of the same irregularly sized electron dense granules that
both cells exhibit, predominately in the preeclamptic glomerular lesion,
but also in other cases of glomerulonephnitis. Previous immunofluores-
cent studies confirm the presence of immunoglobulins, fibrin, C3C, Clq
and albumin in these granules, but not always together in the same case.
In our study we employed a post embedding immunogold technique
using a protein A (PAO) complex as a marker to label the granules of
both cell types with antisera raised against lgA, IgO, 1gM, C3C,
fibrinogen and albumin. Renal biopsy tissue was initially fixed in
periodate-lysine-paraformaldehyde (PLP), post fixed in 1% 0804 for 10
mins., and embedded in L.R. White resin. Ultrathin sections, mounted
on nickel grids, were etched with either sodium m-periodate or hydro-
gen peroxide prior to incubation in the various antisera. The combina-
tion of PLP/0s04 fixation and etching allowed not only for good
preservation of ultrastructure but also for good immunoreactivity.
While most previous electron microscopic studies showed these gran-
ules to be uniform in electron density, some abberation in size and
texture has been observed. In our study of 3 different cases (MCGN
Type I, PET, 000dpasture's syndrome), using a less severe fixation
regime, the granules of both cell types displayed two distinct patterns of
electron density and immunolabeling. A very dense inner core was
strongly positive to anti-fibrinogen, whilst a less dense peripheral zone
was positive to 1gM. All other immunoglobulins and C3C showed a less
specific pattern, whilst albumin was confirmed only in the preeclamptic
lesion. In conclusion, the immunogold marker has detected a storage
pattern in these granules which may well help elucidate the function and
relativity of these cells.
Cyclosporine toxicity: unrelated to immunosuppressive activity. R.J.
Walker, V. Lazzaro, G.G. Duggin, Renal Unit Royal Prince Alfred
Hospital, Camperdown, N.S. W. 2050, Australia. Cyclosporine A (CsA)
nephrotoxicity involves alterations in proximal and distal tubular func-
(ion. The mechanism of toxicity remains unclear. We examined the
effects of CsA and CsH (D-methyl val "Cs), an immunological inert
cyclosporine with apparent minimal nephrotoxicity [I], on cell growth
and cellular synthesis in the pig proximal tubular cell (LLC-PK)
cultures and the distal tubular cell (MDCK) cultures. Cell cultures were
incubated for 2 h, 20 h, 5 days with CsA/CsH concentrations 0.2 to 20
tg/ml. Cell growth expressed as cell count/mi, was measured with a
hematocytometer. Cellular DNA and protein synthesis were measured
as the rate of 3H-thymidine (3HT) and 3H-leucine (3HL) uptake (dpm/ig
protein). High concentrations of CsA and CsH (10—20 g/ml) produced
significant inhibition of cell growth within 20 hr of exposure and led to
cell death (20 g/ml) at 5 days. There was an initial significant increase
in 3HT and 3HL uptake at 2 hr. At 20 hr, 3HT and 3HL uptake was
significantly inpaired (P < 0.01). At 5 days both CsA and CsH produced
increases in 3HT and 3HL uptake at lower concentrations (2—10 sg/ml)
and extensive cell toxicity was evident at 20 g/ml. Thus high CsA and
CsH concentrations have significant toxic effects on proximal and distal
tubular cell cultures with toxicity less evident at lower concentrations.
These observations indicate that CsA and CsH, in this model, induce
cellular damage with ongoing cellular repair which at higher concentra-
(ions is not adequate to maintain cell survival and nephrotoxicity
appears to be unrelated to the immunological activity of the molecule.
I. RYFFEL B, HIESTAND P, FOXWELL B ET AL: Trans Proc 1986:
18(supp 6);4l—45
The relative contributions of volume and osmolality to the control of
circulating inhibitors of NaKATPase in man. D.J. Goodman, A.
Aminian, J.A. Cripps, W.R. Adam, Renal Unit, Repatriation General
Hospital, Heidelberg, Victoria, Australia. The regulation of, and the
contribution to sodium homeostasis of, circulating inhibitors of
NaKATPase is uncertain. To study the relative contributions of
osmolality and volume to the control of circulating inhibitors of
NaKATPase in man, 12 volunteers were given oral sodium loads of
150 mmol for days and blood collected daily for plasma osmolality (P0),
plasma renin activity (PRA) (as a measure of volume) and measurement
of the effect of plasma on oubain-sensitive rubidium uptake in fresh
separated, guinea pig renal tubules (Ru), a measure of the pump
equivalent of the enzyme, NaKATPase. Similar studies were per-
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formed on 14 volunteers prior to, and after, 24 hours dehydration. With
salt loading P0 varied over a range of 260 to 284 m0Sm/kg and PRA
over a range of 0.4 to 6.4 nglmllhr. Ru was directly correlated with PRA
(Ru = 42.7 + 6.37 PRA, P < 0.01) and indirectly with osmolality (Ru
411 — 1.3 P0, P < 0.025). Multiple regression analysis showed a
significant relationship between Ru, PRA and P0, (Ru = 265 + 5.16
PRA — 0.8 P0, P < 0.01). Omission ofPO or PRA from the relationship
had a significant effect. Following dehydration there were significant (P
<0.025) changes in weight (wt) (—1.3 0.3 kg) PRA (+ 1.0 0.3 ng/ml/
hr) Ru (+ 12.8 5.2% of control) and P0 (+4 1.1 mOSmlkg). Ru
correlated indirectly with weight (Ru = 138 — 1.15 wt, P < 0.025) and
directly with PRA (Ru = 15.2 + 0.42 PRA, P <0.025) but not with P0
(P> 0.05). With dehydration, volume is more important than osmolal-
ity as a regulator of circulating inhibitors of NaKATPase. By
contrast, with oral salt loading both volume and osmolality contribute
to the control of levels of circulating inhibitors of NaKATPase.
Morphometric analysis of glomerular features of pre-eclampsia in
Women biopsied in pregnancy and the early post-partum period. D.K.
Packham, D.C. Mathews, K.F. Fairley, J.A. Whitworth, P. Kincaid-
Smith, Department of Nephrology, Royal Melbourne Hospital, Victo-
ria, Australia. In an attempt to resolve the controversy surrounding the
glomerular appearances characteristic of preeclampsia we have per-
formed a morphometric analysis of electron micrographs of glomeruli
from two groups of patients with a clinical and histological diagnosis of
preeclampsia. One group (N = 6) were biopsied either during pregnancy
or at Caesarian section and the other (N = 10) between 3 and 9 days
post-partum. Renal biopsies taken during pregnancy showed substantial
electron-dense subendothelial deposits in capillary loops, but these
were rare or absent in women biopsied post-partum (P < 0.0001).
Endothelial cell swelling was present in both groups of patients to equal
degree. Median percentage of capillary 1oop occupied by lumen was
significantly higher in the post-partum group (P < 0.00 1) and appeared
to be accounted for by the resolution of subendothelial deposits. Thus
preeclampsia is best assessed on biopsy tissue obtained during preg-
nancy or at delivery. Subendothelial deposits are a feature of pre-
eclampsia, but resolve rapidly in the post-partum period. The contro-
versy in the literature almost certainly reflects different timing of biopsy
in relation to pregnancy.
Total body nitrogen (TBN) and nutritional status of patients on
continuous ambulatory peritoneal dialysis (CAPD). C. Pollock, B. Allen,
R. Warden, B. Cocksedge, R. Caterson, J. Mahony, D. Waugh, L.
Ibels, Renal Unit, Royal North Shore Hospital, St. Leonards, N.S. W.,
2065, Australia. In view of observer differences in anthropometric
measurements and inaccuracies of dietary history based on 24 hour
recall, we elected to determine nutritional status in patients on CAPD
utilizing TBN measurements by in vivo neutron activation analysis.
Twenty-nine patients (15 M, 14 F) aged 21 to 78 years (50 14.7, mean
SD) on CAPD for I to 72 months (27.4 19.9) were studied.
Twenty-two patients had utilized CAPD as the sole form of dialysis and
7 had also had intermittent hemodialysis. Comparisons were made with
43 controls (23 M, 20 F). In patients on CAPD, daily protein intake
(DPI) as determined by dietary recall was 1.1 0.47 g/kg. DPI as
determined by urea generation rate was 0.71 0.28 g/kg (P < 0.001).
Body fat (BF) was determined utilizing the sum of triceps, biceps,
subscapular and suprailiac skin folds. Lean body mass was calculated
as body weight—BF. TBN is expressed both as a nitrogen index (NI),
i.e. measured nitrogen/predicted nitrogen for sex and height, and as
nitrogen in g/kg LBM.
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NI was 89% and 88% and nitrogen/LBM was 81% and 82% of normal
for M and F patients on CAPD. We conclude that total body nitrogen is
a useful indicator of nutritional status as standard assessments may not
be reliable.
The effects of OKT3 monoclonal antibody anti-rejection therapy on
intragraft infiltrating leucocytes. P.G. Kerr, R.C. Atkins, Dept.
Nephrology, Prince Henry's Ho.cpital, Melbourne, Victoria, Australia.
OKT3 antibody (Ab) has been used successfully for the treatment of
renal allograft rejection since 1980. However its mode of action,
particularly at the graft level is poorly understood. It is known that the
OKT3 antigen (Ag) is associated with the T-cell antigen recognition
complex. Following OKT3 Ab treatment the OKT3 Ag is no longer
expressed on the T cell surface; this immunomodulation does not affect
other surface antigens (e.g. CD4 or CD8). However, as these changes
have only been described on peripheral blood T cells, we undertook a
study to examine immunomodulation of intragraft T cells in 6 OKT3-
treated patients. This was in an attempt to determine the intragraft
effects of OKT3. All patients received cadaveric grafts and suffered
acute rejection which had failed to respond to 3 x 500 mg i.v. doses of
methyiprednisolone. OKT3 Ab therapy was then instituted, and con-
tinued for 10 days. Needle biopsy specimens of the grafts were
examined before and on dayS of the treatment. Biopsy specimens were
analyzed by routine histology and immunoperoxidase techniques. Pos-
itively labelled cells were counted in 0.2 mm2 of biopsy tissue. The ratio
of the number of OKT3 positive cells to OKTI1 positive cells was used
as a measure of immunomodulation. The results showed that total
leucocytes diminished in each graft following OKT3 Ab treatment (665
78 before treatment; 370 115 after treatment). The intragraft OKT3I
OKTII ratio was 0.94 0.16 before and 0.82 0.26 on day 5 of
treatment. This compares to a peripheral blood ratio of 0.08 0.06 on
day 5 (normal > 0.08); this suggests that OKT3 Ab therapy does not
induce immunomodulation of in situ, intragraft lymphocytes. OKT3 Ab
was notable to be demonstrated in the graft (by application of RAMpx).
Hence OKT3 therapy appears to block the entry of new lymphocytes
into the graft, and possibly has no local effect in the graft at all.
Vascular endothelial cell (VEC) expression of adhesion molecules and
liLA antigens in normal kidney and rejecting renal allografts. R.J. Faull,
G.P. Russ, Renal Unit, Queen Elizabeth Hospital, Woodville SA. The
immune response to vascularized grafts involves both recognition of
1-ILA and adherence of effector leucocytes to their targets by interac-
tion between their adhesion molecules and ligands on target cells. The
pivotal role of VEC as antigen presenting cells, targets of the response
and regulators of effector cell effiux into the interstitium is reflected in
their expression of HLA products and adhesion-related molecules.
Using monoclonal antibodies (Mab) and indirect immunoperoxidase,
this study examines expression of HLA and VEC adhesion molecules in
renal allografts before transplantation and during rejection. The Mab
are RM7.30 (HLA class I), RM5.l 12 (HLA class 11), L243 and RM3.29
(HLA-DR), Genox 3.53 and RM3.49 (HLA-DQ), B7/21 (HLA-DP),
QE7.3E8 (anti-CDI8 complex), 1H4 (anti-ICAM-I) and QE9.IBI andQE9.1D3 (directed against an 88 kDa VEC adhesion molecule). The
normal expression of class I & 11 HLA molecules on intertubular
capillary (ITC), glomerular and venular VEC markedly increases in
rejection with induction on arterial VEC and tubules. The up-regulation
of all 3 HLA-D subsets indicates that all may act as targets in rejection.
Pre-transplant, CDI8 molecules are restricted to ITC and venular VEC,
with induction on arterial VEC in rejection. I-CAM-I is present on all
renal VEC and increases in rejection with appearance on renal tubules.
The antigen recognized by QE9.lBl/lD3 is on all renal VEC and shows
some increased expression on ITC in rejection. Thus, up-regulation of
VEC adhesion molecules occurs in parallel with that of HLA molecules
in rejection, probably secondary to inflammatory mediators, facilitating
increased efficiency of antigen-specific and non-specific cell-cell adhe-
sion during the alloimmune response.
Lmmunoglobulin switch genes and C4 allotypes in Henoch-Schönlein
purpura (liSP). J.F. Knight, D. Briggs, A. Demaine, K.L. Welsh, C.
Chant/er, D.G. Williams, Guy's Campus, UMDS, Guy's Hospital,
London, United Kingdom.As HSP is associated with C2 deficiency and
with HLA B35 and DR4, immunogenetic predisposition may be a factor
in its pathogenesis. We have studied z and a1 switch-restriction
fragment length polymorphisms (RFLPs) (N = 21) and C4 allotypes (N
= 43) in patients with HSP. Southern blots of SSt I digested DNA from
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peripheral blood leucocytes were hybridized with a radiolabelled cDNA
homologue of the Ss region. Frequency of RFLPs in HSP was
compared with 141 Caucasian controls. Plasma was treated with
neuraminidase, electrophoresed, fixed with polyclonal anti-C4 and
stained. C4 allotypes were compared with 39 healthy controls. There
were no differences in Ss or Sn, RFLP frequencies between patients
and controls, in contrast with the increase in the 7 4kb Sn, phenotype
found in IgA nephropathy [1]. Eighteen of 43 HSP patients carried the
C4B null phenotype, of which 3 were homozygous, compared to 5 of 39
controls (1 homozygous), P < 0.0074. HSP is associated with C4B null
phenotype, but not with S or Sa, RFLPs.
1. DEMAINE AG, RAMBAUSEK M, KNKHT JF, WILLIAMS DG, WELSH
KI, RITZ E: Relation of mesangial IgA glomerulonephritis to poly-
morphism of immunoglobulin heavy chain switch region. J Clin
invest (in press
Augmentation of endothelial cell procoagulant activity by supernatants
from isolated cultured nephritic glomeruli. P.G. Tipping, S.R. Holds-
worth, Monash University, Department of Medicine, Prince Henry's
Hospital, Melbourne, Australia. Augmented glomerular procoagulant
activity (PCA) and glomerular fibrin deposition in anti-glomerular
basement membrane antibody-induced glomerulonephritis (anti-GBM
GN) in rabbits is dependent on glomerular macrophage infiltration.
Glomerular macrophages have been shown to express augmented PCA
on their cell surface membranes, but their potential to augment the PCA
of intrinsic glomerular cells by the release of soluble cytokines has not
been examined. To investigate this possibility, glomeruli from rabbits
with anti-GBM GN were isolated and cultured and the supernatants
were collected. Interleukin I (IL-I) bioactivity, measured in a standard
thymocyte proliferation assay, was present in these supernatants (IL-i
3.3 1.9 /ml, normal glomerular supernatants 0.2 0.3 Iml).
Supernatants from nephritic glomeruli markedly augmented the PCA of
bovine endothelial cells in culture (PCA 3.6 0.8 mU/106 cells, control
0.33 0.07 mU/l06 cells), as did purified IL-i (5 1/m1), derived from a
human macrophage cell line (PCA of IL- 1 stimulated endothelial cells
1.2 0.2 mU/106 cells). However, supernatants from nephritic glomer-
uli failed to measurably augment the PCA of normal isolated glomeruli
in culture. These results demonstrate that supernatants from macro-
phage infiltrated glomeruli contain soluble factors which stimulate
endothelial cell PCA. These factors include IL-l. However, as these
supernatants failed to augment the PCA of normal glomeruli, it is
doubtful whether stimulation of the PCA of intrinsic glomerular cells by
macrophage cytokines contributes substantially to the augmented gb-
merular PCA of rabbits with anti-GBM GN.
Crescent formation and lymphocyte activation in IgA nephropathy. N.
Li, D.H. Hooke, J. Dowling, R.C. Atkins, Departments of Nephrology
and Anatomical Pathology, Prince Henry's Hospital, Melbourne, Vic-
toria, Australia. The presence of crescents in IgA nephropathy has
been associated with increased risk of progression to end-stage renal
failure. We have previously demonstrated that the degree of renal
impairment is more closely associated with the degree of interstitial,
rather than glomerular, leucocytic infiltrate. Five patients with crescen-
tic IgA nephropathy were compared with 18 patients with non-cres-
centic IgA nephropathy and 10 normal kidneys. The leucocytes were
enumerated using monoclonal antibodies and a peroxidase-alkaline
phosphatase, double-immunoenzymatic labelling technique. There was
a significant increase in intraglomerular leucocytes in crescentic IgA
nephropathy compared to non-crescentic disease—total: 5.1 0.6 vs.
3.8 0.7; P < 0.01; monocytes 3.1 0.9 vs. 0.7 0.3; P < 0.01, T
lymphocytes 1.4 0.4 vs. 0.7 (0.23); P < 0.01. In the interstitium
appreciable numbers of monocytes (37 13/mm2) and T lymphocytes(29 6/mm2) were seen in normal renal tissue. In non-crescentic and
crescentic IgA disease, there was a significant increase in monocytes;
120 32, 376 184 and T lymphocytes; 283 59, 423 221 cells/mm2.
The difference between interstitial monocyte numbers in non-crescentic
and crescentic was significant (P < 0.01) though not for T cells (P >
0.05). In the crescentic biopsies Tac-l +ve cells were identified within
both glomeruli (1.2 0.5) and interstitium (348 21.3) indicating a
large proportion of infiltrating lymphocytes were activated and ex-
pressed IL-2 receptors. There was no significant difference in the
CD4:CD8 ratios between the two groups. There was a strong correla-
tion between interstitial leucocytes and decrease in creatinine clearance
in patients with crescentic IgA disease. This study demonstrates large
numbers of activated interstitial lymphocytes in crescentic IgA
nephropathy and implicates cellular immune mechanisms in disease
progression.
Plasma cationic proteins in minimal change nephrotic syndrome and
focal gbomerulonephritis. K. Macartney, SI. Perl, B.A. Pussell, iA.
Charlesworth, Renal Unit, Prince Henry Hospital, Little Bay, N.S. W.,
2036, Australia. The pathogenesis of minimal change nephrotic syn-
drome (MCNS) and focal glomerulosclerosis (FGS) remains unknown,
although there is increasing evidence implicating a circulating factor.
The reduction in glomerular polyanion observed in the majority of
patients may be explained by the presence of a circulating cationic
protein which binds to the negatively-charged glomerular basement
membrane and leads to proteinuria. We used heparin affinity chroma-
tography to study the plasma of 21 patients with untreated nephrotic
syndrome (nine MCNS, four FGS, four mesangiocapillary glomerulo-
nephritis, two systemic lupus erythematosus, one amyloid and one
drug-induced) and eight healthy controls. There was a significant
increase in the plasma cationic proteins in the MCNS and FGS patients
when compared to normal controls (P < 0.02) and patients with other
forms of nephrotic syndrome (P < 0.0005). Following induction of
remission in five patients with MCNS their cationic proteins were found
to be significantly less (P = 0.012). Analysis of the protein by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis identified several
abnormal bands in a restricted range (MW 9,000 to 20,000 daltons). We
conclude that there is an increased amount of circulating cationic
proteins in untreated patients with nephrotic syndrome due to MCNS
and FGS.
An ELISA to detect antibodies against neutrophil cytoplasmic antigen
in small vessel vasculitis. J.A. Savige, S.P. Yeung, D.J. Davies, Depart-
ment of Nephrology, Royal Melbourne Hospital, Parkville, and Depart-
ment of Anatomical Pathology, St. Vincent's Hospital, Fitzroy, Victo-
ria, Australia. Circulating antibodies directed against cytoplasmic
components of neutrophils have been described in various forms of
small vessel vasculitis. Here we describe the development of an ELISA
that can be used in the detection of such antibodies. Test sera examined
included those from patients with segmental necrotising glomerulone-
phritis possibly associated with: Ross River virus infection (9); micro-
scopic polyarteritis (acute, 1); and Wegener's granulomatosis (acute, I,
convalescent, 3). Control sera were from patients with rapidly progres-
sive gbomerubonephritis (non-vasculitic, 8); severe IgA disease (11);
anti-glomerular basement membrane disease (6); or contained antibod-
ies directed against DNA (13) or other cytoplasmic components (mito-
chondria, microsomes, La and Jo1); and normal individuals (36).
Dilutions of sera (1/8) were first examined by indirect immunofluores-
cence on peripheral blood smears; all test acute phase sera demon-
strated cytoplasmic staining. Sera were then tested in the ELISA,
which is a modification of the radio-immunoassay described by Savage
et al (Lancet, 1987;i;l389). Mean SD of binding of normal sera was
0.20 0.07 OD units; however control sera with conditions other than
small vessel vasculitis bound at values up to 0.50. All test acute phase
sera bound at levels greater than 0.50; the 3 convalescent phase sera
were negative. Binding of the test sera could be inhibited by pre-
incubation with the neutrophil extract. Preliminary studies with western
blots indicate that anti-neutrophil cytoplasmic antibodies are directed
against a number of high MW structures.
Effects of anti-common leucocyte (CD45R, CD45) monoclonal antibod-
ies on human lymphocyte activation assays. N. Kraft, A. Stein-Oakley,
N.M. Thomson, R.C. Atkins, Department of Nephrology, Prince Hen-
ry's Hospital, Melbourne, Victoria, Australia. The common leucocyte
antigen is expressed on the dendritic cells of the kidney and monoclonal
antibodies to the antigen have been used to ameliorate the renal
albograft rejection responses (Transpl Proc XIX:l96l—1963, 1987). The
antigen has also been used to further subdivide the major T cell subsets
and functional associations have been made with the CD4SR form and
its equivalents in the mouse and rat (Ly-5 Ag and 0X22 defined Ag,
respectively). We have confirmed the enhancing effects of anti-CD45R
antibodies on the human lymphocyte PHA response (5 x 10E4 PBL in
microtiter trays cultured for 3 days) using a panel of reagents from the
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3rd International Workshop on Leucocyte Markers. Nine of 10 anti-
bodies gave >40% enhancement under optimized conditions. At sub-
optimal PHA concentrations (32-fold lower) up to 800% enhancement
was observed. The CD45 (or T200) form has not previously been
reported to have functional effects, but we found 7/12 of such antibodies
to enhance the PHA response, These studies were extended to other
stimulation assays and anti-CD45R antibodies were found to enhance
the responses to PWM, Prot. A, PPD and allogeneic cells. Six of 7 of the
stimulatory CD45 antibodies (PHA assay) also enhanced the early
reaction to allogeneic cells but did not effect the other responses
measured. The mechanism of enhancement is not clear; previous
reports implicated increased IL-2 receptor expression, but our experi-
ments with TAC antibody did not confirm this. Attempts to define the
epitopes involved in enhancement appear to suggest the presence of
large numbers of epitopes. This molecule may be an important tool for
defining the network of cellular interactions required to stimulate the
lymphocyte and further studies are aimed at its role in cell surface
recognition events.
The relevance of urea kinetic modeling (UKM) to CAPD. M. Lysaght,
C. Pollock, K. Schindhelm, L. Ibels, P. Farrell, Baxter (BCMR),
University of New South Wales (CBME), and Royal North Shore
Hospital, Sydney, Australia. UKM is increasingly employed to de-
scribe the quantity and adequacy of hemodialysis (HD), especially
high-efficiency short HD, but is rarely applied to CAPD. Accordingly,
we determined several kinetic model parameters {normalized net
weekly clearance ÷ 3 (Kt/V); residual renal function (Kr); dietary
protein intake (DPI) from both urea appearance rate and protein loss in
peritoneal fluid; and creatinine index (CI)} for 30 CAPD and 35
hemodialysis patients from the same center and with no significant (P
0.05) differences in mean values for age (54) or weight (67 kilos). HD
data were analyzed by established techniques (Gotch et al); CAPD via
24 hour collection of spent dialysate and urine (if Kr > 0):







CAPD 0.6 0.2 0.61 0.3 0.13 0.14 0.9 0.3 15 5
HD 1.0 0.3 0.83 0.2 0.03 0.04 1.1 0.2 21 5
a Significant difference at P < 0.025
The observed difference in Kr for CAPD pts {2.0 mI/mm at 26 3 (5EM)
months} vs. for HD pts (0.7 mI/mm at 36 6 months) may be treatment
dependent. Steady-state CAPD plasma concentration exceed time-
averaged HD concentrations by 39% (urea) and 30% (creatinine). The
interpolated value of MW for which net Kt/V in CAPD first exceeds that
in HD is —2000 Daltons. These studies suggest that UKM for CAPD
patients is technically simple and highly informative, but raise questions
whether the traditional NCDS criteria for a target urea Kt/V of unity is
appropriate for CAPD therapy since, despite lower normalized small
solute clearance, CAPD pts had essentially normal values for the
metabolic assessment parameters of DPI and Cl.
icillin resistance of staphylococci remains prevalent in our unit; how-
ever MRSA isolation has significantly fallen (70%—1978/79: 20%—
1986/87). Methicillin resistance of Staph. epidermidis remains un-
changed (31%). Current antibiotic sensitivity patterns reveal Vancomy-
cm as the most effective single agent (covering 65% of all organisms)
and Vancomycin/Piperacillin theoretically the most effective initial
combination (covers 95% of all organisms). We conclude that there is a
continuing need to review microbiological data relating to the types of
organisms isolated from dialysate so that initial antibiotic therapy can
be decided appropriately. Prevention of peritonitis, however, remains
the major goal in the management of patients on CAPD.
Dialysis-related /32 microglobulin amyloidosis (AMb2m): prevalence
and clinical features in 95 chronic hemodialysis (CHD) patients. A.P.S.
Disney, N.P. Hurst, R. van den Berg, L. Albertyn, M. Alcock, M.
Green, V. Pascoe, Renal and Rheumatology Units, Queen Elizabeth
Hospital, South Australia, 5011. The deposition of AMb2m in various
tissues of dialysis patients after prolonged treatment has been widely
reported. The study was intended to demonstrate the prevalence of
characteristics of the syndrome among all the CHD patients treated
between 1 Jan and 30 June 1987. Ninety-five patients participated in a
clinical, radiological and biochemical survey. The median 1-ID was 4
years (yrs); (0—4.9 yrs, 50 pts; 5—9.9 yrs, 32 pts; >10 yrs, 13 pts). AM
132m was demonstrated by immunofluorescence in the synovia ofjoints
and tendons, in effusions, in bone cysts, and in the carpal tunnel, (all six
operated cases of carpal tunnel syndrome). No correlation with AM
/32m could be established in relation to age, sex, serum f32m level,
ferritin, haptoglobin, C-reactive protein, dialyzer reuse, nephrectomy,
renal disease, and parathyroid status. The only recognizable factor
related to AM 132m deposition was years of dialysis treatment. Of
thirteen patients treated >10 yrs the following features were found; pain
and stiffness in the large joints (hip, knee, shoulder) 100%, carpal tunnel
syndrome (46%), synovitis/effusion in large/medium joints (62%), bone
cysts (64%). Conclusion: AM j32m deposition was related only to
duration of hemodialysis treatment. Joint damage may be disabling and
median nerve compression recurrent. Iron had no detectable relation-
ship to AM /32m deposits. The extent of morbidity warrants consider-
ation of more effective means to limit accumulation of AM f32m in
tissues.
/32 microglobulin on maintenance dialysis. C. Pollock, M. Lysaght, J.
Burrell, T. Brock, P. Farrell, L. Ibels, Renal Medicine, Royal North
Shore Hospital, St. Leonards, and Baxter Centre for Medical Re-
search, North Ryde, N.S.W., Australia. 132 microglobulin derived
amyloidosis is increasingly described in association with long-term
hemodialysis (HD) and in particular dialysis arthropathy. The associa-
tion in patients on continuous ambulatory peritoneal dialysis (CAPD)
remains to be substantiated. The kinetics of /32 microglobulin were
studied in 30 patients on CAPD (12 M, 18 F) and 36 patients on HD (17
M, 19 F) age 52.2 14.2 vs. 55.6 12.1 years (P> 0.05) and weight
66.7 13.9 vs. 66.5 14.3 kg (P> 0.05), respectively (mean so).
Time on dialysis (25.7 17.4vs. 35.9 37.7 months) was longer in the
HD patients although not significantly different. Residual renal function
was significantly greater in the CAPD patients (creatinine clearance
being 1.92 2.38 vs. 0.74 1.52 mI/mm, P < 0.02), Total renal and
dialytic /32 microglobulin is tabulated below.
CAPD—A decade of peritonitis. C.J. Wood, F. Khairuddin, N.M.
Thomson, R.C. Atkins, Department of Nephrology, Prince Henry's
Hospital, Melbourne, Victoria, Australia. An understanding of the
types of organisms causing CAPD associated peritonitis can assist in
the initial management of this common problem. This review analyzes
all peritonitis episodes in our unit since the commencement of CAPD in
1978 and looks at the changing pattern of causative microorganisms,
their antibiotic resistance pattern and the types of organisms commonly
involved in peritonitis relapse. Since 1978, 682 peritonitis episodes have
been documented in the 235 patients trained for CAPD. Our figures
show a steady increase in the frequency of gram negative organisms
(10% to 23% currently), but Staphylococci continue to be the most
commonly isolated organisms (Staph. epi. 41%; Staph, aureus 7%).
Staphylococci are also commonly implicated in recurrent peritonitis
(Staph. epi. 37%, Staph. aureus 20%), but gram negative organisms—
primarily Pseudomonas species are also well represented (20%). Meth-
Quantity of 132 Microglobulin removed (X sn)
Renal Dialytic Total Total
(mg/cl) (mg/cl) (mg/d) (mg/kg/cl)
CAPD 22.78 25.36 34.1 16.1 56.89 23.61 0.91 0.49
HD 21.3 36.0 0 21.3 36.0 0.30 0.47
Dialytic clearance by CAPD was 7.8 0.55 liters per week vs. 0 for
HD. The higher removal rates for CAPD were reflected in lower serum
concentrations of /32 microglobulin being 33.74 12.75 compared with
43.82 10.10, P < 0.001. Whether this has a significant effect on
complications related to /32 microglobulin accumulation remains to be
elucidated.
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132 microglobulin levels in dialysis and transplant patients. J.K. Daw-
born, W.F. Heale, L.P. McMahon, K.J. Pleszcynski, Renal Unit,
Austin Hospital, Heidelberg, Victoria, Australia. 132 microglobulin
levels were measured by radioimmunoassay (Pharmacia) in 30 patients
on long term dialysis, 30 patients with a functioning transplant, 20
patients with chronic renal failure and in a group of normal blood bank
donors. All dialysis patients had markedly elevated levels (12.5 to 71.5
mg/liter compared to a normal range of 1 to 3 mg/liter). There was no
relationship between I2 microglobulin levels and the duration of dialy-
sis or the presence of synovial amyloidosis/dialysis arthropathy. I2
microglobulin levels rose during dialysis with both cuprophane and
cellulose acetate membrane. The effect of highly permeable membranes
and hemofiltration is being assessed. In transplant patients and in
patients with chronic renal failure there was a direct relationship
between the plasma creatinine and plasma 13 microglobulin levels. 132
microglobulin levels fell rapidly after successful transplantation. In
transplant patients with a plasma creatinine less than 0.2 mmol/liter
plasma 132 microglobulin was 3.2 SD 1.2 mg/liter and those with a
plasma creatinine greater than 0.2 mmol/liter 12.0 SD 5.7 mg/liter.
Because of the universally high levels of J2 microglobulin in dialysis
patients and its possible role in synovial amyloidosis, investigations are
required to determine its metabolism and removal. Simple, cost effec-
tive strategies are needed to facilitate its removal, and also long term
studies of its effect and possible amelioration by treatment are needed.
Absorption and excretion of aluminium by the rat intestine. B. Rum-
below, A. Bletas, G. Goddard, M. Cochran, Departments of Medicine
& Clinical Biochemistry, Flinders Medical Centre, South Australia,
5042. The mechanism of Al absorption has been examined in the intact
anaesthetised rat by perfusing segments of gut with buffer of composi-
tion NaCI 100 mri, KHCO3 30 mri, Tris-HCI 10 m'vi, pH 8.5, to which
Aid3 had been added. The range of Al tested was 0—200 M. Radiola-
belIed polyethylene glycol was used to detect water shifts. In the
duodenum, Al was absorbed directly with the perfusate concentration,
the clearance being 1.1 (±0.2 SD) x j_5 liter/min/g duodenum. Portal
blood Al concentration did not increase consistently during the 60
minute perfusion. To test the possibility that enhanced iron uptake
might increase Al absorption, rats were made iron deficient, but had the
same duodenal Al uptake as controls. However the liver Al concentra-
tion in the iron deficient rats tended to be higher. In experiments on the
colon, we unexpectedly found secretion of Al at this site in rats
pre-loaded with the metal. In vitro experiments showed that Al readily
bound to ferritin, to a molar ratio 100 (compared > 1000 for iron) and
that trarisferrin interacted with the iron, but not the Al in the ferntin
molecule. After subcellular fractionation of duodenal mucosa, Al was
located in a heat stable extract of the cytosol, containing the ferritin.
The results showed that Al uptake by the duodenum is passive, but that
the metal can be sequestered in the mucosa. We suggest that mucosal
ferritin behaves as a scavenger molecule for Al, holding the metal until
it is excreted into the gut lumen when the cells are shed. The colon
appears to provide an additional secretory pathway for Al.
Conversion from triple therapy to azathioprine/prednisolone in renal
transplantation. J.R. Chapman, R.D. Allen, S. Lawrence, J.H. Stew-
art, Renal Unit and Department of Surgery, Westmead Hospital NSW
2145, Australia. Triple therapy with cyclosporine, azathioprine and
prednisolone has become an increasingly popular method of immuno-
suppression after renal transplantation. The perceived advantages are
better allograft survival rates and reduced cyclosporine nephrotoxicity
when compared with other regimens. The long term complications of
cyclosporine have yet to be assessed, but problems with hypertension,
hyperlipidemia and nephrotoxicity are all cause for concern. We have
therefore conducted a pilot study of conversion form triple therapy to
azathioprine and prednisolone for long term maintenance. Twenty-
three patients with functioning allografts at 90 days were considered for
conversion. Five patients were not converted because of skin lesions or
poor compliance. Azathioprine was stopped in I patient because of
myelosuppression. Seventeen patients were thus converted by increas-
ing azathioprine to 2.5 mg/kg for I week before reducing cyclosporine
over 2 weeks. Six (35%) patients were diagnosed as suffering acute or
acute-on-chronic allograft rejections between 24 and 271 days after
conversion. No grafts were lost but 5 patients returned to cyclosporine
while I was treated with methylprednisolone only and not reconverted.
While the incidence of rejection after conversion was similar to that
seen when converting from cyclosporine alone, the timing and charac-
ter of rejection were different. A cautious approach and careful moni-
toring are required when stopping the cyclosporine component of triple
therapy.
Results of cadaveric renal transplantation in a smaller unit using
cyclosporin A. E. Savdie, J. Hayes, J. Kelly, Renal Unit, St. Vincent's
Hospital, Darlinghurst, N.S. W., Australia. Since October, 1984 we
have employed cyclosporin A (CsA) as the principal immunosuppres-
sive drug in our cadaveric renal allograft programme. In the three years
to October, 1987, 31 such grafts (23 first, seven second and one third)
were performed in transfused recipients, 27 using CsA and low-dose
prednisolone initially with intention to change CsA to azathioprine
(Aza) after 3—6 months; and the last four using CsA, Aza- and
prednisolone ab initio in a triple therapy regimen. Actuarial patient
survival was 100% at three months and thereafter 96% at six, 12 and 24
months. Actuarial graft survival was 79% at three months and 76% at
six, 12 and 24 months. These results compare favorably with the most
contemporary (1983—1986) data available for CsA-treated grafts in
Australia (1987 AKF Registry Report). One patient died, from pulmo-
nary emboli complicating Pneumocystis infection five months after
grafting. Principal causes of graft loss were early renal vein thrombosis
(two) and persistent early non-function associated with acute rejection
(two). There were 16 elective conversions to Aza 12—39 weeks (mean
18) after grafting in the initial 27 patients, but of these only six
proceeded uneventfully, although no grafts were lost. Four patients
experienced acute rejection, all requiring pulse steroids and two requir-
ing recommencement of CsA. A further four patients developed possi-
ble or probable Pneumocystis pneumonia soon after conversion. These
results demonstrate that good results are obtainable with CsA even
when transplant volumes are small. They also reinforce the problems
associated with CsA conversion and the predisposition of CsA-treated
patients to infection with Pneumocystis.
An improved technique for percutaneous biopsy of the transplanted
kidney. JR. Chapman, R.M. Jones, R.D. Allen, MS. Dunnill, P.J.
Morris, Renal Unit and Department of Surgery, Westmead Hospital
NSW 2145, and Nuffield Department of Surgery, Oxford University,
England. Biopsy of the transplanted kidney has become increasingly
important since the advent of cyclosporine because of the difficulty of
diagnosing rejection on clinical and biochemical criteria. Percutaneous
biopsy using a 14 G Tru-Cut needle, when performed by trained hands,
yield biopsies of good quality, however, there is a low but appreciable
complication rate. We have assessed the possibility of using a thinner 18
O needle fired by an automatic pistol grip (Radiplast, Sweden). Renal
allograft biopsies were attempted on 174 consecutive occasions. In 9
instances no renal material was taken, attributed in each case to the
position of the kidney being poorly defined while in 14 biopsies only
renal medulla was sampled. Thus tissue adequate for diagnosis was
obtained in 87% of attempts. The mean number of glomeruli was 7.6
(range 0—26) and arteries were sampled on 132 occasions. Macroscopic
hematuria occurred in 4 patients (2%) and no patients required surgical
intervention. There were no other complications and the procedure was
tolerated well by all patients who were kept on bed rest for 4 hours after
the biopsy and then permitted to go home if their urine was macroscop-
ically free of blood. The study has shown that a thinner but full length
needle core biopsy of the transplanted kidney can provide diagnostic
material at the cost of few complications, The main advantage of this
technique is that repeated biopsy of the renal allograft can now safely be
performed as an outpatient procedure.
Transplantation of rat kidneys following perfusion with anti-Ia mono-
clonal antibody. P. Jablonski, N. Kraft, B. Howden, N.M. Thomson,
R.C. Atkins, and V. Marshall, Monash Dept. Surgery & Dept. Nephrol-
ogy, Prince Henry's Hospital, Melbourne, Victoria, Australia. Mono-
clonal antibodies (Ab) are already being used to perfuse transplanted
human kidneys in attempts to modify graft rejection (Transpl Proc XIX:
194—193, 1987). The Ab used is directed against an epitope of the
common leucocyte antigen expressed on the interstitial dendritic cell.
We have used a rat model (DA into AS) to explore this approach.
Isolated kidneys were perfused with 0X6 anti-Ia common Ab (in 5%
BSA—isotonic citrate containing Na 78 m, citrate 54 mM, Mg 40
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mM, SO4 =40 mM, C1 1 mM, pH 7,1) at 4°C for 16 hr. Other perfusion
times from 3—24 hours yielded the same degree of immunohistological
staining of dendritic cells by the Ab. These kidneys were transplanted
heterotopically in 8 AS rats (150—200 g) with immediate autonephrec-
tomy; a control group received kidneys perfused without added Ab.
Rejection was monitored by rising serum creatinine concentrations
which occurred after 5 days in both groups. All animals died and there
was no significant difference between groups (Ab-treated on day 6, 7, 7,
7, 7, 8, 8, 8 of control on day 7, 7, 7, 8, 8, 9, 10). Biopsies were taken
after perfusion and at 1, 3, 4, and 24 hours after transplantation in order
to monitor the presence of Ab. These showed labelled dendritic cells in
all biopsies at 0 and 1 hour; after 3—4 hours only 50% had strong
labelling but some label was found in all specimens. After 24 hours one
biopsy showed no label, the other 2 were weakly labelled. However,
dendritic cells were still present in undiminished numbers as deter-
mined by immunohistological staining following freshly applied 0X6 Ab
to the stored sections. We conclude that this failure may be due to the
loss of Ab from the dendritic cell after 4 hours. We suggest that this
form of monitoring will be necessary in the selection process of suitable
reagents which may modify the allograft response.
Effect of allopurinol superoxide dismutase and catalase on renal
transplants in the rat. B. Howden, P. Jablonski, M. Biguzas, A,
Thomas, K. Walls, V.C. Marshall, Monash Department of Surgery,
Prince Henry's Hospiial, Melbourne. lschemia results in the loss of
adenosine triphosphate, its dephosphorylation to adenosine diphos-
phate and monophosphate, further degradation to adenosine and hypo-
xanthine, and the activation of xanthine oxidase. On revascularization,
oxygen-derived free radicals are generated and cell membrane and
mitochondrial damage ensues. Administration of a xanthine oxidase
inhibitor (allopurinol), or free-radical scavengers (superoxide dismutase
[SOD] and catalase) has been shown to ameliorate warm ischemic
damage. This study examines the efficacy of such treatment on rat
kidney grafts damaged by prolonged (48 hours) cold preservation. All
kidney grafts were flushed in situ and preserved by continuous perfu-
sion with 5% BSA/phosphate buffer/sucrose, pH 7.1, 300 mOsm/kg, 18
mllhr at 4°C. Grafts were transplanted heterotopically after 48 hours.
Recipients received: (i) allopurinol, (ii) SOD, (iii) catalase, (iv) SOD
plus catalase, or (v) saline just prior to revascularization. Nephrectomy
of the recipient kidney was delayed for 5 days. All saline and allopurinol
treated animals survived; one SOD, one SOD plus catalase and two
catalase treated rats died. The GFR was impaired in all groups and
treatment with allopurinol or free-radical scavengers did not improve
GFR or significantly affect polyuria and sodium loss which is a
characteristic of the damaged rat kidney. Conclusion: Allopurinol and
free radical scavenger treatment of the recipient in the immediate
post-transplant period was ineffective after prolonged cold preserva-
tion. These findings suggest that damage induced by warm ischemia and
by cold ischemia may be mediated by different mechanisms, and that
metabolic inhibitors and free radical scavengers are less effective for the
latter.
Lack of xenoantibody response in recipients of renal transplants
pre-treated with anti-human leucocyte common antibody. M.A .B.
Thomas, G.M. Lloyd, K.!. Welsh, Renal Unit & Department of
Molecular Immunogenetics, UMDS, Guy's Campus, London, United
Kingdom. Use of xenogeneic monoclonal antibodies for prophylaxis
against or treatment of acute graft rejection is usually complicated by
the development of host antibodies to the foreign protein which limit
effectiveness of further therapy. To determine whether administration
of a mixture of two rat monoclonal anti-human leucocyte common
antibodies directly to the renal allograft prior to transplantation reduced
the incidence of xenoantibody formation, we developed a sensitive
solid-phase ELISA for human IgG anti-rat IgG antibodies and screened
the first 39 patients so treated. The assay was sensitive to a dilution of
1:5000 of the reference positive serum, specific as demonstrated by
significant fluid-phase inhibition by rat or mouse lgG, but not rabbit
IgG, and had an intra-assay coefficient of variation of 17.2%. The
normal range (mean 2 SD, N = 25) was 0 to 34%; positive samples
were confirmed by reassay after fluid-phase inhibition by rat IgG for I
hr at 37°C. Results were expressed as % of known standard serum. Only
2 of 39 patients were found to have inhibitable anti-rat IgG antibodies
(levels = 190% & 300%). Pretransplant sera from these patients showed
mildly elevated ELISA optical densities, but no inhibition by rat IgG, a
pattern found in a further 5 post-transplant sera. This study has shown
xenoantibody formation in only 5% of transplant recipients were rat
monoclonal antibody was administered directly to the donor kidney
pretransplant. Whether this mode of therapy is associated with im-
proved graft survival and fewer rejection episodes is the subject of a
double-blind trial.
Terminal complement components, S-protein and SP-40,40 in renal
biopsies. B.F. Murphy, D.J. Davies, W. Morrow, Renal Unit and
Anatomical Pathology, St. Vincent's Hospital, Melbourne, Australia.
The terminal complement complex has been implicated in the develop-
ment of glomerular injury both in experimental and, indirectly, in
human glomerulonephritis (GN). Recentdata suggests that the terminal
complement complex in human GN is in the cytolytically inactive
SCSb-9 form containing the S-protein. We have recently identified a
new component of SC5b-9, called SP-40,40. (J Gun Invest, in press).
We prospectively examined by immunofluorescence 90 consecutive
renal biopsies to determine the incidence and inter-relation of deposi-
tion of the SC5b-9 components C6, C9, S-protein and SP-40,40, in
addition to routine examination for immunoglobulins (Ig), Clq, C3, and
fibrin. Components of SC5b-9 were found in arteries and arterioles,
along the tubular basement membrane (TBM) and in areas of glomeru-
losclerosis in all biopsies. This deposition was sometimes associated
with C3 but never Ig deposition and correlated with the degree of renal
injury. Vascular and TBM deposits of SC5b-9 were particularly marked
in interstitial nephritis and allograft rejection. In addition, in biopsies
with glomerular deposition of Ig and C3 (membranous GN 9, IgA GN
16, SLE 10), the SC5b-9 components colocalized with the immune
deposits. Glomeruli without immune deposits or glomerulosclerosis
contained none of the SC5b-9 components. The incidence and pattern
of distribution of SP-40,40 was similar to that of S-protein, C6 and C9 in
nearly all cases. These data confirm that the terminal complement
complex in the kidney is, at least partly, in the SCSb-9 form, both in the
specific immune glomerular deposition and in the "non-specific" dep-
osition in areas of renal injury. SP-40,40 is also found in the SC5b-9
complex in all forms of renal disease.
Genomic sequence of the a3 chain of type IV collagen. J.A. Savige,
B.A. Evans, R.I. Richards, P. Kincaid-Smith, Department of Nephrol-
ogy, Royal Melbourne Hospital, and Howard Florey Institute, Univer-
sity of Melbourne, Victoria, Australia. The "Goodpasture antigen"
(GPA) is situated within the non-collagenous domain of the a3 chain of
type IV collagen, which is the principal protein of the glomerular
basement membrane (Butkowski et al, JBC 1987;262:7874). The area is
clinically relevant since antibodies are directed against certain epitopes
in this region in Goodpasture's syndrome and a segment of the
non-collagenous domain containing the GPA may be absent in some
forms of hereditary glomerulonephritis. Structural definition of this
region has defied conventional biochemical techniques. Here we de-
scribe the identification of the genomic sequence of the a3 chain. A
probe 45 oligonucleotides long corresponding to human codon prefer-
ences for the amino acid sequence of bovine lens capsule was made. A
human cosmid library was obtained from Dr. Choo (Murdoch Institute,
Royal Children's Hospital, Melbourne) and the number of colonies
corresponding to 4 genomes screened with radio-labelled probe in 20%
formamide at 42°C. Duplicate filters were washed in 0.2 x SSC at 50°C
and autoradiography performed overnight. Two positive clones were
obtained, and the DNA was extracted using the alkaline lysis method,
Restriction enzyme analysis demonstrated that these overlapped. A Sau
3a fragment of one clone has been subcloned into BamHl-cut Ml 3 and
is currently being sequenced. We intend to use an expression vector
and immunological screening to determine the epitopes of the GPA.
Expressed protein can then be used as the basis of an ELISA for the
diagnosis of Goodpasture's syndrome. A subcloned fragment can also
be used to screen peripheral blood DNA of patients with hereditary
glomerulonephritis in order to define a genetic marker.
Cross-reactivity of anti-DNA antibodies with glomerular heparan sul-
phate and streptococcal peptide. M.A.B. Thomas, D.G. Williams, Renal
Unit, UMDS, Guy's Hospital, London, United Kingdom. Anti-DNA
antibodies (DNA Abs) are not specific to SLE but also occur in
infections, including post-streptococcal glomerulonephritis (PSGN),
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schistosomiasis mansoni and filariasis complicated by nephritis. Pa-
tients with PSGN have antibodies against heparan sulphate (HS) and a
nephritis strain-associated peptide (NSAP). The aim of this study was
to examine cross-reactions between DNA Abs and antigents (Ags)
associated with these infections. Serum from a patient with SLE and
high DNA Abs was diluted to 75% max. signal and incubated with
varying amount (7.5 pg to 7.5 ng) of the above Ags then antiDNA Abs
assayed by ELISA. Results are expressed as ng of Ag giving 50%
inhibition vs. buffer alone. There was dose-dependent inhibition by
ssDNA (0.085), dsDNA (75), HS (2,500) and NSAP (7,000). There was
no significant cross reactivity against S. mansoni egg Ag, filarial worm
Ag or bovine serum albumin (polyanion control). Inhibition by HS and
NSAP was unchanged by DNase digestion; DNA, HS and NSAP did
not show any nonspecific blocking activity in related Ag-Ab systems for
S. mansoni or filariasis; and the high DNA Ab serum did not exhibit
direct binding to another GBM Ag, the Goodpasture Ag. These results
suggest that streptococcal infection may induce the formation of
autoantibodies which recognize glomerular basement membrane com-
ponents, providing a potential immunopathogentic mechanism in
PSGN, but not demonstrated in the tropical nephropathies we studied.
Glomerular macrophages produce interleukin 1 in experimental gb-
merulonephritis. P.G. Tipping, M.G. Lowe, S.R. Holdsworth, Monash
University, Department of Medicine, Prince Henry's Hospital, Mel-
bourne, Australia. Interleukin I (IL-I) is a potent inflammatory medi-
ator which is released from glomeruli in human and experimental
glomerulonephritis (GN). Both macrophages and glomerular mesangial
cells have the potential to synthesize IL-i. The relative contributions of
these cells to IL-I production in GN is unknown. To address this
question, glomeruli were isolated from rabbits with passively induced
anti-glomerular basement membrane antibody-induced GN (anti-GBM
GN). Their IL-i production in culture, measured in a standard thy-
mocyte proliferation assay, was markedly augmented (147 31 tJl06
glomeruli/hr, normal 2.3 2.7 tJl06 glomeruli/hr). Gbomeruli isolated
from rabbits given anti-GBM antibodies, but depleted of circulating
monocytes, did not show but depleted of circulating monocytes, did not
show increased IL-I production (5.3 6.0 sJl06 gbomeruli/hr). Glomer-
ular macrophages isolated from nephritic rabbits demonstrated aug-
mented IL-I production (175 77 jsJl0 cells/hr) compared to blood
monocytes (21.1 12.3 dl06 cells /hr) and alveolar macrophages (11.0
6.3 iJl06 cells/br) isolated from the same animals. These results
demonstrate that glomerular IL-I production in anti-GBM GN is
dependent on the presence of macrophages, and that glomerular mac-
rophages have enhanced capacity for IL-i production. This suggests
that infiltrating macrophages are the predominant cell responsible for
glomerular IL-I production in this model of GN.
The kinetics of proliferation of cultured rat mesangial cells. Y. Kaki-
zaki, R.C. Atkins, Department of Nephrology, Prince Henry's Hospi-
tal, Melbourne, Victoria, Australia. In order to study the kinetics of
proliferation in cultured rat mesangial cells, thymidine uptake was
measured and cellular DNA content was analyzed by flow cytometry.
Mesangial cells, 2 x l0 well, were plated into 96-well microplates in
RPM! with 20% fetal calf serum. After 24 hours mesangial cells were
placed in RPM! with varying concentrations of fetal calf serum and
incubated for varying time periods. Mesangial cells were then pulsed for
varying time periods. Mesangial cells were then pulsed with I tCi of
3H-thymidine for 18 hr and the radioactivity was counted. Quantitative
labelling of cellular DNA was performed by modified Krishan's
method, using propidium iodide. Thymidine uptake by mesangial cells
was exponentially increased in 20% fetal calf serum, while it was not
increased after 4 days in 10% and 5% fetal calf serum, and it decreased
by degrees in 1% and 0.5% fetal calf serum. When mesangial cells
maintained a low concentration of fetal calf serum for 4 days were
placed in 20% fetal calf serum, thymidine uptake was markedly increased
by day 6. In mesangial cells maintained in 20% fetal calf serum, the
percentages of cells in GO/U!, Sand G2/M phases were 69.3, 16.2 and 14.5
on day 1, 82.2, 8.4 and 9.4 on day 5, and 90.7, 3.2 and 6.1 on day 7
(confluent state). This study demonstrates the dose dependent effects of
FCS on the proliferation of exponentially growing mesangial cells and
growth-arrested mesangial cells. The analysis of cellular DNA content is a
useful method of assessing the proliferation of mesangial cells.
Normal glomerulo-tubular balance is maintained for sodium in the
presence of natriuresis produced by atrial natriuretic factor in the rat. S.
Reddy, C. Cochineas, D. Kelly, and A.Z. Gyory, Departments of
Medicine, University of Sydney and Renal Medicine, The Royal North
Shore Hospital of Sydney, St. Leonards, 2065. Glomerulo-tubular (GT)
balance for sodium means that fractional sodium excretion (FENa) is
maintained constant in the face of variations of GFR, implying that as
GFR increases absolute sodium reabsorption also increases, and vice-
versa. The mechanism for this phenomenon is unknown. The natriure-
sis of volume expansion (YE) is accompanied by a disturbance of GT
balance. In this whole kidney study, the relation between changes in
GFR and FENa was investigated in rats anaesthetised with mactin and
infusions of ANP 11 and saline YE separately or together, and in the
presence and absence of converting enzyme inhibition (CE!). The table
gives slopes, correlation coefficients and 'p' values for regressions
between FENa and GFR, and shows that with ANP, but not with yE,
GT balance is maintained.
Slope 'r' D
ANP (18) 2.42 0.31 0.213
YE (16) 3.53 0.59 0.016
ANP + VE (24) 3.42 0.32 0.132
ANP + CEL (16) —0.62 0.38 0.144
VE + CE! (16) 4.12 0.53 0.035
ANP + YE + CE! (22) 5.70 0.75 0.0008
These data indicate that the mechanism which produces natriuresis with
ANP probably does not involve that responsible for GT balance. YE on
the other hand disrupts GT balance. CE! when combined with ANP or
YE does not interfere with the effects on UT balance of either. These
results emphasize that the natriuresis of ANP and YE are caused by
different mechanism(s).
Methylprednisolone-induced distal tubule cysts in vitro. C.J. Roe, R.
Whitehead, R.G. Walker, P.S. Kincaid-Smith, Department of Nephrol-
ogy, Ludwig Institute for Cancer Research, Royal Melbourne Hospital,
Parkville, Victoria 3050. The pathogenesis of cystic kidney disease
remains unknown. The following in vitro model allows for the study of
the morphological characteristics of developing tubule cysts. Segments
of NZW rabbit renal tubules obtained by microdissection were sus-
pended in collagen gel and bathed in RPM! 1640 medium containing
10% FCS, I g/ml hydrocortisone, 0.6 g/ml insulin, l0- Ma thiogly-
cerol, 50 iu penicillin, 50 iu streptomycin, 10 g/ml epidermal growth
factor and incubated at 37°C in 5% CO2 in air for 14 days. Methylpred-
nisolone 0.02 tg/mI (MP) hydrocortisone 0.1 g/ml (HC) or PBS(C) was
added on Day 6. Cultures were assessed daily by phase contrast
microscopy and by light microscopy at the termination of the experi-
ment on Days 10 or 13. There was no difference in appearance between
HC treated and C cultures. In the MP treated cultures both centrally
and peripherally located distal nephron tubule cysts appeared. These
were lined by a single layered epithelium and contained cellular debris
in their lumen. This new in vitro model of distal nephron cyst formation
makes possible the morphological study of cyst pathogenesis.
The interaction between urate crystals and cultured renal tubular cells.
M. Cross, R. Axelsen, B.T. Emmerson, Department of Medicine,
University of Queensland, Princess Alexandra Hospital, Brisbane,
4102. Models of gouty nephropathy have postulated a reaction between
urate and uric acid crystals and distal tubular lining cells as one of the
initiating steps. A continuous cell line of canine kidney cells (Madin-
Darby or MDCK) with many of the characteristics of distal renal
tubular cells was exposed to urate crystals and the response studied
both morphologically and biochemically. Defined reaction sites were
visible in the cell monolayer at 12 hrs, increased to a peak at 48 hrs. and
subsided subsequently. Scanning EM showed crystals which were
partially enveloped by cell processes and transmission EM showed
crystals within the cell. Ultimately crystals were demonstrable beneath
the tubular epithelial monolayer of the heaped up reaction sites. Release
of lysosomal and to a lesser extent, cytosolic enzymes was demonstra-
ble, the extent being proportional to both crystal concentration and the
duration of exposure. Similar responses were achieved with MDCK
cells grown in suspension and with exposure to uric acid crystals in an
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acid medium such as occurs in tubular fluid. It is concluded that such
cell-crystal interactions provide a useful study of the pathogenesis of
crystal nephropathy.
Poly aspartic acid (PAA) prevents experimental gentamicin nephrotox-
icity despite increased intracellular G. W.M. Bennett, P.W. Kohnen,
D.N. Gilbert, Oregon Health Sciences University, Portland, Oregon,
USA. PAA, a 15,000 dalton amino acid polymer has been reported to
inhibit G binding to renal tubule brush border and basolateral mem-
branes. To study whether this has implications for in vivo nephrotox-
icily, groups of male Fisher rats were given G 20 mg/kg bid with PAA
380 mg/kg, sterile water or equimolar NaCl. At 10 days renal structure
and function were assessed by BUN, creatinine clearance, fractional
excretion of sodium (FENa), N-acetylglucosaminidase (NAG) and light














0 39 0.6 0.9 297 81
G + Na 47 0.5 l.8 l89' 151
G + PAA 18 1.4 0.6 2866*a 16
PAA alone 18 1.3 0.5 — 19
Control 22 1.1 0.7 — 19
p <0.01 from 0 + PAA; * p < 0.001 from G and G + Na
G + PAA had no tubular necrosis. All PAA animals had intracellular
vacuoles without obvious effect on cell integrity. G was localized by
immunoperoxidase techniques within cells despite the absence of renal
dysfunction. PAA did not affect in vitro antibacterial effects of 0.
Conclusion: PAA prevents experimental G nephrotoxicity. Intracellular
accumulation of G was dissociated from toxicity raising questions about
the currently accepted pathogenesis of G nephrotoxicity. PAA had a
fundamental nephroprotective action which could be exploited clini-
cally.
Cyclosporin induced hypertension: studies in conscious sheep. J.A.
Whitworth, W.M. Bennett, J.P. Coghian, J.G. de Lima, J.G. McDou-
gall, J.J. Tresham, B.A. Scoggins, Howard Fiorey institute of Exper-
imental Physiology and Medicine, and Department of iVephrology,
Royal Melbourne Hospital, Victoria, Australia. Cyclosporin A (CyA)
causes significant hypertension in clinical practice. In previous studies
we showed that CyA raised mean arterial pressure (MAP) in conscious
sheep via increased peripheral resistance, in the absence of a fall in
glomerular filtration rate (GFR). In the present studies we have exam-
ined renal and haemodynamic effects of Cyclosporin D (CyD) and its
vehicle, and pressor responsiveness to CyA. CyD at 12 mg/kg/day for 5
days caused only a transient rise in MAP, a persistent increase in heart
rate and no change in GFR or renal blood flow. Vehicle did not produce
any consistent changes. CyA at 12 mg/kg/day for 5 days produced a
sustained increase in MAP from 68 2 to 82 3 mm Hg (p < 0.001) and
heart rate from 67 4 to 91 4 beats/mm (P < 0.001). Pressor
responsiveness to graded infusions of angiotensin II, vasopressin,
serotonin and noradrenaline were unchanged by CyA. Indomethacin
treatment increased MAP but this effect was not changed by CyA. Our
data suggest that different analogues of cyclosporin have different
effects on blood pressure. Changes in pressor responsiveness to hu-
moral agents do not appear to contribute to the CyA induced resistance
mediated hypertension. The drug may exert its effect on vessels
directly.
A positive relationship between serum ionized calcium and blood
pressure In a population of working men. I.B. Puddey, D.A. Jenner, R.
Vandongen, L.J. Beilin, Department of Medicine, University of West-
ern Australia, 35 Victoria Square, Perth, Western Australia. The
finding of reduced serum ionized calcium levels in case control studies
of small numbers of hypertensive subjects has been cited as evidence
for a role for dietary calcium deficiency in the pathogenesis of hyper-
tension. However, this observation has been difficult to rationalize in
the light of positive relationships between total plasma calcium, 24 hr
urinary calcium excretion and level of blood pressure (BP) in several
population studies. We have therefore measured these variables to-
gether with serum ionized calcium in a population-based study of 343
working males from 2 public utilities. Serum ionized calcium correlated
positively with age (r = 0.14, p = 0.01), body mass index (BMI) (r =
0.19, p <0.001) and both systolic and diastolic blood pressure (r = 0.18,
p = 0.001 and r = 0.16, p <0.01, respectively). After adjustment for age
and BMI, a significant positive relationship between serum ionized
calcium and systolic, but not diastolic, BP was still observed. Total
plasma calcium correlated only with systolic BP (r = 0.12, p < 0.05), a
relationship which no longer held after adjustment for plasma albumin,
age and BMI. Twenty.four hour urinary calcium excretion correlated
positively with both systolic and diastolic BP (r = 0.18, p = 0.001 and
r = 0.11, p = 0.05, respectively) but after adjustment for age and weight
only the relationship with systolic BP remained significant. These
observations are not consistent with the hypothesis of dietary calcium
deficiency in hypertensive subjects, but may be indicative of a state of
relative hyperparathyroidism.
Renal basement membrane glycosylation In experimental diabetes
mellitus (DM): progression is prevented by islet transplantation. K.
Nicholls, T. Mandel, Department of Nephrology, Royal Melbourne
Hospital and Transplantation Unit, Waiter and Eliza Hall Institute,
Parkvi!le 3050, Australia. Non-enzymatic glycosylation (NEG) of pro-
tein is a common mechanism of structural and functional organ damage
in DM. We quantitated NEG of renal basement membrane in strepto-
zotocin (STZ)-induced murine DM, and studied the effect of successful
islet transplantation. Female BALB/C mice aged 6—8 weeks received
STZ 250 mg/kg IV. After 6 months of untreated hyperglycemia, diabetic
animals were divided into 2 groups and compared with appropriate
controls:
Group A — continued hyperglycemia, intermittent insulin;
Group B — allografted with cultured islet cells;
Group C — age matched controls;
Group D — STZ injected animals, non-diabetic.
After sacrifice (age 12 months group A, 15 months groups B, C, D),
renal basement membranes were isolated by sonicaiding, then purified
and collagenese.digested. NEG was quantitated by autofluorescence of
the digests, and expressed as arbitrary units per g hydroxyproline:
Group n NEG—median (range)
A 6 17.0 (6.0—25.4) ** p < 0.01 (vs. B, Kruskal-Wallis)
B 10 3.9 (<0.5—15.9) NS
C 6 1.2 (<0.5—9.0)
D 7 1.6 (<0.5—5.9) NS
We conclude that untreated DM greatly increases glycosylation of renal
basement membranes, and that islet transplantation after 6 months of
untreated DM, effectively retards progression of this process.
The Tasmanian renal failure survey—1987. N.W.J. Oliver, J.M.
Walsh, T. Dwyer, R.G. Fasselt, J. W. Freeman, f.M. Sands, Renal
Unit, Royal Hobart Hospital, Tasmania. The incidence of end-stage
renal failure (ESRF) varies between and within different countries. In
Australia, glomerulonephritis (GN) and analgesic nephropathy (AN)
account for about 50% of primary renal disease progressing to ESRF
and dialysis. In Tasmania the annual acquisition of patients onto
dialysis is half that of the national average (22, cf 44 patients/million
p.a.). The difference is mainly in the small number of patients with GN
(about 20% of average) and virtually no AN. During 1987 laboratories in
Tasmania have notified creatinine and/or urea values 230 pinol/liter
and 14 mmol/liter. By October 1987, diagnostic information had been
obtained in 800 patients. In the full year the number will be about 1200.
Analysis of a sample of 133 patients has shown that 82% are 60 and over
with an annual mortality rate of 25%. Including hypertension and
diabetes, primary renal disease only accounted for 44% of the total.
Severe renal failure with a S. creatinine 500 and/or a B. urea 35
occurred in only 24% of the patients who died and 12% of the survivors.
Many deaths occurred in elderly patients with terminal cardiovascular
disease and cancer, and uremia was incidental. A 73 year old with
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severe, generalized diabetic vascular disease died in ESRF, otherwise
no patients <80 years died of untreated ESRF. The incidence of proven
GN was only 3% and a presumptive diagnosis of AN was made in 3%.
The completed survey and the significance of the findings will be
presented.
Glomerulonephritis, pulmonary hemorrhage and anemia associated
with campylobacter jejuni (Cj) gastroenteritis—A novel case. P.!. An-
drews, G. Kainer, L.C.J. Yong, A.R. Rosenberg, Department of
Nephrology, The Prince of Wales Children's Hospital, Randwick, and
Department of Anatomical Pathology, Prince Hen,y Hospital, Little
Bay, NSW, Australia. A previously well, 5-year-old girl suffered Cj
enteritis and over the next few weeks developed hematuria, proteinuria,
anemia and recurrent hemoptysis. She had radiographic changes con-
sistent with pulmonary hemorrhage and hemosiderin laden macro-
phages were present in her sputum. Her serum creatinine rose to 0.14
mmol/liter. Renal biopsy at 10 weeks revealed widespread tubular
atrophy, interstitial fibrosis and cellular infiltration. Of 20 glomeruli 12
were totally sclerosed and 5 contained cellular crescents; there was
mesangial proliferation in the non-sclerosed glomeruli. Mesangial gran-
ular deposits of IgG, 1gM, Clq and C3 were identified. Cj antigen (using
a fluorescinated rabbit anti-Cj antibody) was found in the same distri-
bution. The patient's hemoptysis and respiratory status improved with
cyclophosphamide and prednisolone but her renal function has contin-
ued to deteriorate slowly. Ci infection has been reported preceding
acute clinical glomerulonephritis and has also been associated with
immune mediated disorders such as Guillain-Barre syndrome and
reactive arthritis. However, there have been no reported cases of a
Goodpasture-like syndrome and Cj antigen has not previously been
identified in renal biopsy material. While the pathological mechanism in
this case is uncertain, circulating immune complex disease appears
most likely,
Prognosis and sex in adult refiux nephropathy. M.T. El-Khatib, G.J.
Becker, P. Kincaid-Smith, Department of Nephrology, Royal Mel-
bourne Hospital, Victoria, Australia. Presenting features and course
were studied in 293 adults, 244 female (F), 49 male (M). ratio 5:1, with
reflux nephropathy &/or primary vesicoureteric refiux. Age at presen-
tation was similar (mean 31.5 12.4 F; 31.0 14.4 M). Most F (72%)
and only 31% of M presented with urinary tract infection (UT!) (P <
0.005). Pregnancy related presentations occurred in 9% of F. In M
proteinuria (20% cf F 4%, P < 0.001) and hypertension (29% cf F 18%,
NS) were the main other causes of presentation. At presentation M had
more severe disease, with more frequent bilateral scarring (70% cf F
50%, P < 0.001), bilateral reflux (50% cf F 29%, P < 0.025), a higher
mean plasma creatinine (0.36 0.36 cf F 0.18 =1— 0.23 mmol/liter, P <
0.001) and urinary protein excretion (1.37 1.28 cf F 0.59 1.10 g/24
hrs, P < 0.001). The prognosis was studied in the 147 patients (126 F,
21 M) followed for 2 years or more (mean 6.9 3.6, range 2 to 15 years).
The relative risks (RR) of a rise in plasma creatinine by >0.02 mmol/
liter for each feature at presentation were: proteinuria> I g/24 hrs, RR
= 48.3; plasma creatinine > 0.11 mmollliter, RR = 24.3; bilateral
scarring RR = 7.5; male sex RR = 6.7 and hypertension RR = 4.6.
Multiple regression analysis was used to see whether sex was an
independent risk factor. This showed that once urinary protein and
plasma creatine were taken into account, male sex had no independent
influence. This study suggests that the main reason for the disparity in
sex incidence in adult reflux nephropathy is the F presentations with
UTI & pregnancy complications.
Renal and metabolic abnormalities in calcium stones disease. R.S.
Nanra, P. Hall, S. Nanra, Department of Nephrology, Royal New-
castle Hospital, Newcastle, New South Wales, Australia. One-day
renal function tests (ODRFT) were performed in 29 controls (mean age
34.5, SD 11.4 yrs) and 37 patients with calcium stones (mean age 43.6,
SD 15.6 yrs, female:males = 18:19). The stone formers had: reduced
GFR (55—76 mI/mm/I .73 m2 sa, 25%); impaired concentration capacity
(529 to 869 mOsm/kg H20, 74.2%); sodium depletion (U Na/Cr 0.8 to
11.9, 29.7%); hyperuricemia (0.39 to 0.55 mmol/liter, 21.6%), hyper-
uricosuria (U uric acid/Cr 0.45 to 0.65, 13.5%), and increased uric acid
clearance (14.5 to 19.3 ml/min/1.73 m2 sa, 10.1%); hypercalcemia (2.51
mmol/liter, I patient) and hypercalciuria (U Ca/Cr 0.7 to l.7, 29.7%);
acidifying defect (mm U pH 5.3 to 5.6, 11.1%), renal tubular acidosis
(RTA) (mm U pH > 5.6, 11.1%), hypocitraturia (0.03 to 0.26 mmol/day,
8.6%), reduced excretion of titratable acid, ammonium and total acid
(52.8%, 77.8% and 66.7%, respectively); hypokalemia (3.1 to 3.4 mmol/
liter, 18.9%); hypophosphatemia (0.59 to 0.84 mmol/liter, 29.7%) with
increased % fractional excretion of phosphate (20 to 25.8, 13.5%); and,
proteinuria (0.14 to 2.6 g/day, 27.8%). Serum bicarbonate, parathyroid
hormone (17 patients) and urine oxalate excretion were noimal in all
patients studied. Conclusions: (I.) Patients with calcium stones have
significant renal and metabolic abnormalities. (2.) These findings are
relevant in stone disease management. (3.) The ODRFT is a convenient
method for assessing these abnormalities.
Congenital polycystic renal disease in guinea pigs. A new model. D.J.
Lewis, L.J. Cussen, Victorian Paediatric Dialysis and Transplantation
Unit, Monash Medical Centre, and Department of Paediatrics, Mo-
nash University, Clayton, Victoria, Australia. Congenital polycystic
disease of the kidneys evolved by spontaneous mutation in a closed
colony of guinea pigs. Parents of affected animals and their unaffected
offspring were mated and 12 generations of affected animals resulted.
Autosomal recessive inheritance was confirmed by F, hybrid cross-
breeding. Affected guinea pigs were identified by enlarged kidneys
detected after birth, and were either stillborn or survived for up to 5
days. At necropsy, organs were weighed and studied by light micros-
copy. The kidneys were also examined by microdissection and by
histochemical techniques, and the lungs by radical alveolar counts.
Congenital polycystic renal disease in guinea pigs has similarities with
human infantile polycystic renal disease, as both present with enlarged
kidneys at birth and are associated with a shortened life expectancy.
The major differences are that the cysts occur predominantly in the
proximal tubules and loops of Henle in affected guinea pigs, whereas
they mainly involve the collecting ducts in the human disease, and that
there are no cystic or hyperplastic changes in the liver of the guinea
pigs. The affected guinea pigs do not have hypoplastic lungs. This
model provides an opportunity to assess the development and conse-
quences of cystic change in the guinea pig kidney.
Interstitial fibrosis in lithium and non-lithium treated young NZW
rabbits infected with Encephalitazoon cuniculi. C.J. Roe, R.G. Walker,
P.S. Kincaid-Smith, Department of Nephrology, Royal Melbourne
Hospital, Parkville, Victoria 3050, Australia. Previous studies have
shown that interstitial nephritis, a chronic progressive cystic lesion and
impaired renal function develop in adult rabbits fed lithium over 12
months. Additionally, in rats, younger animals are more susceptible to
lithium-induced changes over 16 weeks. This study investigates the
effect of chronic lithium exposure in young rabbits found to be infected
with Encephalitazoon cuniculi. Eighteen 6-week-old NZW rabbits, 6
controls (C) and 12 treated (Li) (75—175 mmol Li Cl/kg food aiming for
a plasma lithium level of 0.5—1.0 mmol/liter) were followed over 6
months. All rabbits had free access to water. Weight was measured
weekly, plasma lithium fortnightly and serum creatinine, urea, Ca,
HCO3, AST and ALT monthly. E cuniculi serology and closed renal
biopsy were performed at 6 months. Distal tubule luminal area was
quantitated by digitization (Hewlett Packard 9874A). One C rabbit died
at 4 weeks. There were no differences in weight gain or serum
creatinine, urea, Ca, or HCO3 levels between Li and C at 6 months.
Mean (± SD) plasma lithium concentration was 0.70 (± 0.13) mmol/liter
for Li. Positive serology and abnormal liver function tests were present
in all animals. At 6 months distal tubule mean luminal area was
significantly greater for Li (3.3 0.8 sq units) compared to C (1.5 0.6
sq units, P < 0.001). Perivascular fibrosis was present in both Li and C
rabbits. These data demonstrate that by 6 months interstitial nephritis
occurs in young rabbits with E cuniculi infection independent of lithium
exposure. In addition lithium treatment is associated with distal tubule
dilatation, but without associated deterioration in renal function.
Increased age at the commencement of dialysis of patients with anal-
gesic nephropathy. J.J.B. Petrie, J.R. Burke, R.J. Rigby, P.G. Row, J.
O'Connor, B. T. Emmerson, Renal Unit and Department of Medicine,
Princess Alexandra Hospital, Brisbane, Queensland, Australia. In 1978
the sale of compound analgesics without prescription became illegal in
Queensland. It was decided to assess the effect of this legislation on the
pattern of analgesic nephropathy. Patients accepted for dialysis and/or
transplantation at the Princess Alexandra Hospital from 1968 to 1977
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inclusive [period 1] were compared with those accepted from 1982 to
1987 inclusive [period 113. The total number of patients commencing
dialysis in period I was 346, of whom 85 (25%) had AN. For period ii
the total was 352 of whom 64 (18%) had AN. This difference in
incidence just reaches significance (P 0.049). The mean age of
patients with AN starting dialysis in period I was 44.7 5.9; for period
11 it was 53.1 6.4 (t = 12.9; P < 0.001). Patients were subdivided
according to age at the start of dialysis. In period 192 patients under the
age of 30 began dialysis, as compared to 68 in period II. No patient had
AN. In period 1188 patients aged 30 to 49 began dialysis; 66 (35%) had
AN. in period II 125 patients aged 30 to 49 began dialysis; 19(15%) had
AN (P = 0.0004). For period 166 patients over the age of 50 commenced
dialysis; 19 (30%) had AN. For period lithe total in this age group was
159; 45 (28%) had AN (P = 0.93, NS). There has been a marked decline
in the incidence of analgesic nephropathy in patients under the age of
50; over age 50, however, AN remains an important cause of end-stage
renal failure. It seems likely that few new cases are occurring; the
majority of patients presenting for dialysis today with AN probably
sustained major renal damage prior to 1978.
Arteriolar C3 disease: A 10 year experience. C. Pollock, L. Ihels, R.
Eckstein, Renal Medicine, Royal North Shore Hospital, St. Leonards,
N.S.W., 2065, Australia. Afferent arteriolar staining for C3 was dem-
onstrated as the main histological finding in 117 patients of 978 patients
undergoing renal biopsy. Thirty-two patients were then excluded from
analysis on the basis of(i) systemic disease known to involve the kidney
with or without non-specific renal biopsy involvement, (ii) non-specific
light, immunofluorescent or electron microscopic changes apart from
age-related glomerularsclerosis (30), arteriolar wall thickening (8), mild
increases in mesangial matrix (8) or light mesangial or capillary wall
1gM deposition (17). Five patients were excluded on the basis of thin
basement membranes of a focal or diffuse nature. Of the 85 patients (61
F, 24 M) aged 18 to 71 years (40.2 12.3, mean sD), 78 presented
with hematuria and 40 with co-existent loin pain. Associated conditions
included hypertension 14.5%, urinary tract infection (UT!) 14%, UT1
and calculi 4%. Follow up to 95 months (34.9 23.2) showed no
deterioration in renal function, with follow-up creatinine clearance
being 100 19 mI/mm, Proteinuria >150 mg/day occurred in 17 patients
(400 310 mg/day) of whom 10 had subsequently normal urine protein
loss. Hematuria and loin pain persisted throughout follow-up. Studies
of first order relatives suggest autosoma! dominant inheritance. Com-
parison of patients with arteriolar C3 disease and 13 patients with thin
basement membrane disease showed no difference on clinical parame-
ters. We conclude that afferent arteriolar C3 deposition is a common
histological finding, particularly in patients presenting with loin pain
and hematuria. Prognosis is excellent with respect to renal function but
persistent loin pain is a problem. Differentiation between thin basement
membrane disease is not possible on clinical grounds alone.
Alcohol directly alters the renal water transport. C. Ray, S.L. Carney,
Faculty of Medicine, University of Newcastle, Newcastle, NSW,
Australia. Most studies have shown that acute alcohol administration
promotes a diuresis in both humans and animals by inhibiting the
secretion of vasopressin (AVP). Since a recent report failed to show a
suppressive effect of alcohol on plasma AVP in man, and since there is
a lack of information on the direct effects of alcohol on renal function,
the following studies were devised to evaluate the effect of differing
concentrations of alcohol upon water transport in the collecting duct.
Papillae from water diuretic rats were removed and placed in a media
where superficial papillary collecting ducts were perfused with a
perfusate isotonic to the bath. The unidirectional diffusion of water was
measured both in the absence and in the presence of increasing
concentrations of alcohol (0.12, 0.24, 0.48, 0.96, and 1.92 g%) as well as
with submaximal (20 sU/ml) and maximal (200 sU/ml) concentrations
of AVP. Basal diffusional water permeability (without AVP) was
significantly increased 9.2%, 9.9% and 18.5% by the addition of 0.12,
0.96 and 1.92 g% of alcohol, respectively. With the addition of a
submaximal concentration of AVP, diffusional water permeability was
significantly increased by the addition of low concentrations of alcohol
(0.12, 0.24 and 0.48 g%) but depressed by higher alcohol concentra-
tions. However, despite these facilitatory and inhibitory effects of
alcohol upon water transport, maximal concentrations of AVP were
unaffected by all concentrations of alcohol. These results show that
alcohol, at concentrations commonly found in social and heavy drinkers
can alter basal and AVP-induced water transport. These changes,
however, favor an antidiuretic effect of alcohol rather than a diuretic
effect; such an effect is well documented although not well known in
man.
The role of peripheral vascular resistance in ACTH-induced hyperten-
sion. C.D. Spence, A.D. Brown, J.P. Coghian, J.A. Whitworth, B.A.
Scoggins, Howard Florey Institute of Experimental Physiology and
Medicine, and Department of Nephrology, Royal Melbourne Hospital,
Victoria, Australia. ACTH administration to sheep produces a rapid
increase in arterial pressure (MAP) cardiac output (CO), and heart rate
(HR). Both /3-adrenoceptor blockade and autonomic ganglion blockade
prevent the HR-dependent increase in CO, but do not abolish the
hypertension, which under these circumstances is mediated by in-
creased calculated total peripheral resistance (CTPR). This study
examined the effects of vasodilating drugs on the onset of ACTH
hypertension. The hemodynamic response to ACTH (5 pg/kg/day) was
assessed in 8 sheep. MAP rose by 21 2 mm Hg (P < 0.001) and CO
by I.! 0.1 1/mm (P < 0.001) after 3 days. Infusion of the calcium
channel blocker, nisoldipine (0.6 mg/kg/day) with ACTH (N = 4)
completely prevented the onset of hypertension. CO increased from 5.4
0.1 to 9.0 0.3 1/mm (P < 0.001) and CTPR fell from 11.7 0.3 to
7.2 0.7 mm Hg. minlliter (P < 0.001). Nisoldipine alone (N = 4)
transiently reduced MAP by 2 1 mm Hg (P < 0.05) over 48 hr and CO
increased by 1.4 0.3 liter/mm (P < 0.001) after 24 hr, but was not
changed after 4 days. Similar results were obtained using the direct
acting vasodilator, minoxidil. Thus ACTH induced increase in blood
pressure is not dependent on changes in CO but can be abolished when
CTPR is decreased. This suggests that ACTH hypertension in sheep
may involve a vasoconstrictor mechanism.
Angiotensin II: Effects on blood pressure and sodium excretion in
human pregnancy. M.A. Brown, F. Broughton Pipkin, E.M. Symonds,
Department of Renal Medicine, St. George Hospital, Sydney, Australia
and Department of Obstetrics, Queen's Medical Centre, Nottingham,
England, United Kingdom. Normal pregnancy is characterised by
refractoriness to the pressor effects of angiotensin 11 (All), a phenom-
enon lacking in women with pregnancy-induced hypertension (P1H), a
sodium retaining disorder. To study the effects of All upon sodium
excretion in normal human pregnancy a graded intravenous infusion of
All was given following intravenous saline loading (3 mmol sodium/kg)
to 12 first trimester pregnant women. Twelve comparable control
pregnant subjects received the saline infusion alone and eight non-
pregnant women had both protocols, thus acting as their own controls.
In both groups All produced: (1) a dose-dependent pressor response (ii)
a graded increase in plasma aldosterone concentration (PAC) (iii) a
reduction in sodium excretion, largely due to a fall in filtered sodium but
also due to tubular sodium reabsorption. Pregnant and non-pregnant
women had similar pre-study plasma renin concentration (PRC) though
PAC was elevated twofold in the pregnant group. PRC and PAC were
suppressed in both groups following saline loading and A!! stimulated
PAC in a dose dependent manner but did not further alter PRC.
Although stimulation of PAC was proportionally similar in pregnant and
non-pregnant subjects for a given dose of All, both sodium retention
and pressor effects were more marked in non-pregnant women. This is
the first report of refractoriness to the pressor effects of All as early as
the first trimester of human pregnancy. This study also demonstrates
refractoriness to some renal effects of All by this stage of pregnancy
and an early dissociation between the renin-angiotensin system and
PAC in normal pregnancy.
Chronic angiotensin converting enzyme inhibitor treatment in the
2-kidney, 1-clip hypertensive rat. B. Jackson, L. Franze, E. Sumithran,
C.!. Johnston, University of Melbourne, Department of Medicine,
Austin Hospital, Heidelberg, Victoria, Australia. Angiotensin convert-
ing enzyme inhibitor treatment in renovascular hypertension produces
acute effects on renal function, the long-term consequences of which
are not known. We have studied the effect of chronic enalapril treat-
ment on renal structure and function in the two-kidney, one-clip model
of renovascular hypertension in the rat. Four weeks after clipping the
left renal artery, hypertensive rats were randomized to treatment with
enalapril (E, N = 25), minoxidil (M, N = 33) or no treatment (C, N =
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37). Drug dose was titrated for hypotensive effect. Twelve months later
survivals were 84% (E), 48% (M) and 15% (C). Creatinine clearance was
similar in all groups. Split kidney function (51Cr EDTA clearance, ml!
mm) of the clipped kidneys were 0.00 (E), 0.26 0.23 (M) and 0.74
0.13 (C), and of the non-clipped kidneys were 1.49 0.19 (E), 0.47
0.26 (M) and 0.69 0.19 (C). The clipped kidney from E rats weighted
(g)0.46 0.10, much less than in M (1.2 0.07, P <0.001) or C (1.14
0.10, P < 0.001). Enalapril treatment was ceased for 2 weeks (N = 5).
The clipped kidney remained small and non-functional. Histological
examination showed marked interstitial fibrosis and tubular atrophy in
clipped kidneys from both E groups, in contrast to minor changes in M
and C groups. Vascular injury was prominent in the non-clipped kidney
from C, modest in M, and absent in E rats. Chronic enalapril treatment
of 2-kidney, 1-clip hypertension in the rat improved survival and
preserved total renal function, but was associated with irreversible
fibrotic atrophy of the clipped kidney.
The natriuresis of atrial natriuretic peptide is specifically inhibited by
converting enzyme inhibitors independent of blood pressure changes. S.
Reddy, C. Cochineas, D. Kelly, A.Z. Gyory, Department of Medicine,
University of Sydney and Renal Medicine, The Royal North Shore
Hospital of Sydney, St. Leonards, 2065 Australia. We have previously
shown that concurrent converting enzyme inhibition (CEI) greatly
attenuated the natriuretic actions of synthetic atrial natriuretic peptide
(ANP). However, the lowering of mean arterial pressures (MAP)
produced by CE! and ANP together, could have contributed to signif-
icant non-specific reductions of sodium excretion. In the present
experiments the effect of simultaneous infusion of CEI (Captopril, N =
10), or vehicle alone (Placebo, N = 14) and ANP, subsequently
superadded noradrenalin (NE) infusion, to elevate MAP to control
values, was examined. Rats were anaesthetised with mactin i.p., and
urine collected for FENa estimations. Plasma renin activity in the CE!
rats was 223 12 and 5.2 1.1 ng/ml!hr in non-CE! rats (mean SE)
showing adequate suppression of CE.
MAP mm Hg FENa %
CE! Placebo CE!Placebo
Control 134 0.9 115 1.9C 0.15 0.02 0.57 0.09C
ANP 89 2.2 80 24b 1.55 0.12 1.37 0.21
ANP ÷ NE 109 1.3 !05 !.0 2.4 0.28 1.20 0.15
Significant difference from Placebo: ' <0.05; b <0.0!; C <0.001
Thus, returning the MAP to the normal range did not enhance the
suppressed natriuretic actions of ANP due to CE!, although NE alone
without CE! increased natriuresis. This confirms our previous conclu-
sion that CE! specifically inhibits the natriuretic actions of ANP. The
mechanism of the inhibition of the natriuresis of ANP by CEI is at
present unknown.
The effect of atrial natriuretic peptide (ANP) on transport along the
nephron. G.G. Allen, L.M. Sherry, L.J. Barratt, Renal Unit, Flinders
Medical Centre, Bedford Park, South Australia. The tubular site of
action of ANP remains controversial. We investigated ANP effect on
loop function by its influence on TCH2O and CH2O and its action on
proximal and distal tubules by measuring transepithelial potential
differences (pds). TCH2O studies were performed on Ginger-hooded rats
(Groups I & 2) given exogenous pitressin and infused with hypertonic
saline (1.2%) at increasing rates of delivery (100—750 sl/min). Urine and
midpoint blood samples were collected for each infusion period to allow
urine flow rate (V) and osmolality measurements. CH2O studies were
performed on Brattelboro rats (Groups 3 & 4) infused with hypotonic
saline (0.18%). ANP was infused in Groups 2 & 4 at 0.5 sg!kgImin.
Results: TCH2O values were significantly depressed by ANP in the
higher Cosm ranges in comparison to controls: 184.9 8.2 (Group 2)
c.f. 219.5 4.5 d!min (Group I) in the Cosm range 400—600 pi!min (P
<0.001). CH2O was significantly depressed by ANP at all levels of 2V
e.g. 138.4 9.6 (Group 4) c.f. 205.4 10.7 sl/min (Group 3) in the V
range 400—600 sl!min (P < 0.001). In Groups 5 & 6 free flow transepi-
thelial pds were measured in proximal and both early and late distal
tubules. Measurements were made during an initial control period and
subsequent period of continuing Ringers infusion addition of ANP. In
early distal segments ANP induced a reduction in the magnitude of the
normally positive pd from +7.2 0.8 mV to +3.3 1.4 mV (P <0.04)
but no significant change was noted in either proximal or late distal
segments. Conclusions: ANP induces a depression of TCH2O and CH2O
in the rat suggesting an inhibition of NaCI transport in the ascending
limb. The reduced pd in early distal segments may reflect a change in
composition of the fluid delivered to these segments.
The effect of treatment with prednisolone (P) or cyclophosphamide-
warfarin-dipyridamole combination (CWD) on outcome of patients with
membranous nephropathy (MN). A.R. Clarkson, J.D. Shearman, A.J.
Woodroffe, I. Aarons, P.D. Smith, G. Y. Zhou, Renal Unit, Royal
Adelaide Hospital and Department of Renal Pathology, 1.M.V.S.,
Adelaide, Australia. Between 1973 and 1986, 109 patients with mem-
branous nephropathy have been evaluated with respect to clinical
presentation, pathological features and factors determining prognosis.
Secondary disease was present in 21 and a further 2! were lost or
followed for less than 12 months. The remaining 67 with idiopathic MN
were allotted to: GROUP 0—no treatment, (26 patients); GROUP 1—
CWD as in Australian Trial (12 patients); and GROUP 2—P as in USA
Collaborative Study (21 patients). Eight patients received other treat-
ment or presented with ESRD. At the end of the follow up outcome was
defined as: remission (proteinuria < I g!24 hrs, normal plasma creati-
nine), proteinuria (proteinuria > I g, normal plasma albumin and
creatinine), nephrotic (continued nephrotic syndrome ENS], normal
plasma creatinine), deterioration (development of renal impairment)
and ESRD (need for dialysis). Persistent NS or deteriorating renal
function implied progressive disease. No significant difference in out-
come could be detected between GROUPS I and 2 when compared with
GROUP 0. Remission rates were equivalent as were numbers of
patients judged as having progressive disease (GROUP 0; 6, GROUP 1;
3, GROUP 2; 6). There was no statistical difference between groups
with respect to duration of NS, plasma creatinine at end of study and
change in plasma creatinine. No demonstrable benefit was obtained in
predicting outcome of disease or response to treatment from conventional
histological grading of stages I to 4, as approximately equal numbers of
each stage fell into good and bad categories of outcome. Unusual histo-
logical features such as mesangial proliferation and immunofluorescence
for deposits other than lgG and C3 were similarly unhelpful.
Renal vein thrombosis in childhood: A review of 5 cases. D.J. Lewis,
L.J. Cussen, V. Y.H. Yu, and M. Mclver, Victorian Paediatric Dialysis
& Transplantation Unit, Neonatal Intensive Care Unit, Monash Med-
kal Centre & Department of Paediatrics, Monash University, Clayton,
Victoria, Australia. Five children with renal vein thrombosis (RVT)
treated over the past IS years were reviewed. All infants developed
RVT in the neonatal period. Three infants were preterm born at 25, 32
and 34 weeks and had severe neonatal problems. All were hypertensive
at the time of acute presentation. The remaining two infants were born
at term and one had no documented precipitating event; neither infant
was hypertensive acutely. The diagnosis of RVT was made by ultra-
sound following the clinical finding of a renal mass with hematuria in
four patients and during routine investigation for neonatal hypertension
in one preterm infant. One infant had inferior vena caval extension and
was anticoagulated; the remaining four were treated conservatively.
Three of the five children later developed hypertension at 18 months to
7 years from the time of the acute RVT. All three children had a small
nonfunctioning kidney on the side of the RVT. Two children had
elevated renal renin concentrations from the affected kidney. Two
children underwent nephrectomy and are normotensive without anti-
hypertensive medication. One infant remains hypertensive on Captopril
and is being considered for nephrectomy. Renal vein thrombosis is an
uncommon but treatable cause of hypertension occurring in childhood.
Hypertension may be present during the acute episode but the possi-
bility of the later development of hypertension necessitates long-term
follow up of these infants.
Use of 1.deamino-8-D-arginine vasopressin (DDAVP) in correction of
prolonged skin bleeding time (SET) in patients with renal disease. M.B.
Fraenkel, L.J. Barratt, A .S. Gallus, Flinders Medical Centre, Bedford
Park, South Australia. DDAVP has been reported to correct the
bleeding disorder of uremia and does not involve the use of blood
products. SBT has been shown to be a useful indicator of clinical
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bleeding. Since May 1985 we have used DDAVP in correction of
prolonged SBT inpatients with chronic renal failure (Group I)and those
with normal to moderately impaired renal function (Group 11). INR,
APTT, CBP and SBT were performed routinely prior to renal biopsy,
angiography or surgery. In Group 1 (107 tests in 42 patients) SBT
exceeded 14 minutes on 14 occasions in 10 patients. In Group 11(120
tests in 114 patients) SBT exceeded 7 minutes in 6 patients (2 had
normal renal function). INR, AP1'T and platelet count were consis-
tently normal. Of those with prolonged SBT, II from Group I and all 6
from Group II received IV DDAVP (0.4 meg/kg), andSBT was repeated
l—2 hours later. In Group I SBT fell from values exceeding 16 minutes
(9 outof Ii exceeded 20 minutes) to a mean of 10 1.5 mm (P <0.001).
InGroup II SBT fell from a mean of 18 Ito 8.5 2 mm (P < 0.005).
DDAVP produced no adverse effects and no bleeding complications
were experienced during the subsequent procedures. A sustained
reduction in SBT was obtained when therapy was continued via the
intranasal route in one patient. Non-symptomatic hyponatremia devel-
oped during therapy. Conclusion: Despite normal LNR, APT1' and
platelet count, SBT (an indicator of clinical bleeding) was prolonged at
some time in 25% of patients with chronic renal failure (8% of tests).
Two patients with normal renal function and 4 with mild to moderate
renal impairment also had a prolonged SBT. SBT was significantly
reduced by IV DDAVP and no bleeding complications were experi-
enced in the subsequent procedures.
Pregnancy in women with diffuse mesanglal proliferative glomerulone-
phritis D.K. Packham, R.A. North, K.F. Fairley, E. Lee, P. Lloren,
J.A. Whitworth, P. Kincaid-Smith, Department of Nephrology, Royal
Melbourne Hospital, Victoria, Australia. The clinical courses of 168
pregnancies in 91 women with non IgA diffuse mesangial proliferative
glomerulonephritis have been analyzed to determine effects on mother
and baby. Results were analyzed using the chi-squared test. Twenty
percent of pregnancies resulted in fetal loss, 18% in premature delivery
and 62% in a term infant. Maternal renal function declined, reversibly,
in 3% of pregnancies and in 48% hypertension developed. In 53% a
significant increase in proteinuria occurred in pregnancy. Fetal and
maternal complications of pregnancy were apparently more frequent in
patients with pre-existing hypertension, but this was not significant.
The presence of severe vessel lesions on the diagnostic renal biopsy
was associated with a higher fetal loss and pre-maturity rate (P < 0.001
and P < 0.005, respectively). Although the majority had a successful
pregnancy outcome without long-term maternal sequelae, women in
this series had an increased risk of fetal and maternal complications
during pregnancy. Severe renal vascular lesions were particularly
associated with poor fetal outcome.
Atraumatic rhabdomyolysis, acute renal failure and malignant hy-
perpyrexia. D.F. Dwyer, B.P. Hurley, M.A. Denborough, Renal Unit,
Royal Canberra Hospital and Department of Medicine and Clinical
Science, John Curtin School of Medical Research, Australian National
University, Acton, ACT 2601, Australia. Five patients with severe
atraumatic rhabdomyolysis underwent muscle biopsy and in vitro
contracture studies specific for malignant hyperpyrexia (MH). The
precipitating cause of rhabdomyolysis was extreme exertion and dehy-
dration in two subjects, and in the others severe Legionella pneumonia,
status epilepticus with alcohol abuse and phenothiazine administration,
respectively. Serum creatine phosphokinase (CK) levels ranged from
20,000 to 150,000 lU/liter and all but one patient developed acute renal
failure (ARF). Three required dialysis and all survived with recovery of
normal renal function. At least one month elapsed after serum CK
levels returned to normal before muscle biopsy was performed. Sus-
ceptibility to MH was assessed on the basis of contracture responses of
muscle to halothane, suxamethonium, caffeine and potassium chloride.
By this means MH muscle was demonstrated in three patients, two of
whom had developed ARF; in the fourth patient who developed ARF
contracture responses were clearly abnormal though without full spec-
ificity for MH; in the fifth patient who developed ARF responses were
normal, excluding MH. These results suggest that MH muscle disease
may be a common though not universal underlying cause of atraumatic
rhabdomyolysis with associated ARF.
Renal papillary necrosis (RPN) and chronIc Interstitial nephritis (CIN)
with nonsterioidal anti-inflammatory drugs (NSAIDS)—Comparison with
the analgesic syndrome. R.S. Nanra, Department of Nephrology, Royal
Newcastle Hospital, Newcastle, NSW, Australia. The renal lesions
found in 26 patients who had taken NSAIDs continuously for at least 9
months were: (1) CIN in 6l.9% (confirmed by renal biopsy in 12 of 13
patients), (2) RPN in 30.8%, (3) deterioration in function in 4 patients
(15.4%) with pre-existing analgesic nephropathy (decline in GFR of 10
to 27 mI/mm), and (4) membranous nephropathy in 1 patient (3.9%).
Sixteen patients took multiple NSAIDs and 10 patients took single
NSAIDs (3 naprosyn, 2 paracetamol, 2 indomethacin, 2 ibuprofen and
I diclofenac) over periods of 9 months to over 20 years. The clinical
syndrome in the 21 patients with CIN and RPN ((I) + (2)) was
compared with the syndrome associated with analgesic abuse (100
patients) seen between 1984 and 1986. The important differences in the
NSAIDs group were: lower female: male ratio 1. 1: 1; absence of pa-
tients with GFR < 20 mI/mm; and less renal osteodystrophy. Although
the NSAID group appeared to have milder disease, there were no
differences in: abuse of laxatives, cigarettes and alcohol; pyuria,
hematuna and proteinuria; renal size and nephrocalcinosis; secondary
gout; hypertension and cardiovascular complications; and gastrointes-
tinal and hematological manifestations. The mean age of the patients
were similar (60.4, SD 12.2 yrs) and one NSAID patient developed a
transitional cell tumour of the bladder. Conclusion: The misuse of
NSAIDs may lead to (1) CIN and RPN, and further deterioration in
pre-existing analgesic nephropathy, and (2) a clinical syndrome similar
to the analgesic syndrome.
Body fat status in patients on continuous ambulatory peritoneal dialysis
(CAPD). J.F. Collins, L. Olsen, S. Hannan, S. Streat, G.L. Hill,
Departments of Medicine and Surgery, Auckland Hospital, Auckland,
New Zealand. Studies in patients on CAPD show that body weight
(b.wt) increases substantially over the first year of treatment. In
contrast, when anthropometry is used to assess their body fat many
patients are thought to have reduced fat stores, which seem to change
little with time on CAPD. Using the techniques of in vivo neutron
activation analysis to measure total body nitrogen (TBN) and tritium
dilution to measure total body water (TBW), we were able to apply a
compartmental analysis, previously validated by cadaveric studies, to
the precise estimation of total body fat content (TB fat) in 21 stable
CAPD patients on treatment for a mean of 22.8 months (range 4—78). TB
fat = b.wt — (TBN x 6.25 + TBW + total body mineral* + total body
glycogen*). *Estimates based on formulae. TB fat was compared to an
estimate of total body fat using anthropometric measurements (TB
fat-AN; Durnin & Womersley): TB fat = 22.37 8.4 kg (range 9.63—
36.6); TB fat-AN = 19.98 8.6 kg (range 7.7—38.8). TB fat-AN
systematically and significantly underestimated TB fat (P < 0.05). The
CAPD patients were compared to a sample of 112 normals evaluated
with the same techniques, using regression equations based on age, sex
and height. Mean TB fat was (1.33 0.52) x predicted TB Fat. Six
patients were >1 SD above that predicted, none were <I SD below that
predicted. In summary: (1) Estimates using standard equations based
on skin-fold anthropometry underestimated fat stores in CAPD pa-
tients; (2) Stable CAPD patients are fatter on average than would be
predicted from a normal sample.
Ultrafiltration in patients on continuous ambulatory peritoneal dialysis
(CAPD). C. Pollock, B. Cocksedge, L. Jbels, J. Mahony, R. Caterson,
Renal Medicine, Royal North Shore Hospital, St. Leonards, N.S. W.,
2065, Australia. in order to assess ultrafiltration and dialysis character-
istics of patients on CAPD, 12 patients were assessed by sampling of
peritoneal fluid for concentrations of Na, K, HCO3, glucose, urea,
creatinine, protein and osmolality after complete drainage and at times
0, 1, 15, 30, 60, 90, 120, 180 and 240 minutes after instillation of 2 liters
2.5% dialysate with 100 g albumin. Residual peritoneal volume was
calculated utilizing the mean of values based on initial dilution of K,
urea and creatinine. Four patients were considered to have poor
ultrafiltration and adequate dialysis, and 8 patients were considered to
have adequate dialysis and ultrafiltration. Comparison of the 2 groups
utilizing a mixed model analysis of variance was then undertaken to
address whether the groups differed significantly in any parameter
pooled across time points and also whether the differences vary at any
particular time point. Total glucose absorption assessed by 24-hour
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dialysate specimens was higher in those with poor ultrafiltration al-
though no significant difference was evident at any time point. No
difference was demonstrated in urea and creatinine clearance over time
and peritoneal osmolality did not fall at a higher rate in those with
impaired ultrafiltration. The major difference demonstrated was that
those with poor ultrafiltration had significantly higher Na in the dialy-
sate (P < 0.05). One patient was studied on 3 occasions over 12 months
with varying degrees of ultrafiltration capacity. No consistent pattern in
any parameter over time was demonstrated. We conclude that ultrafil-
tration characteristics are not explained on simple peritoneal transfer of
osmotically active substances although Na transfer may play a more
significant role than has been previously appreciated.
Acute clinical evaluation and kinetic modeling of mixed mode ESRD
therapy. M. Lysaght, J. Moran, J. Hayes, P. Farrell, Baxter Centre for
Medical Research, UNSW, St. Vincents Hospital of Melbourne and
Sydney, Australia. In order to compare and contrast solute removal and
adequacy between CAPD and hemodialysis, we designed and acutely
evaluated a protocol in which patients were treated on a reduced CAPD
schedule (2 bags @ 4 hours each; 16 hours dry belly) supplemented by
a once weekly hemodialysis session (kt/vol = 1.2 — 1.8). To date, 4
patients have been studied after a baseline control period: mean age =
56; mean weight = 60 kg; mean residual renal function = 1.6 mI/mm
(range 0 to 4.1); mean urea nitrogen generation rate = 5.0 mg/mm, and
mean creatinine index = 18 mg/kg/day. Urea and creatinine concentra-
tions, measured pre- and post- each days' CAPD exchange, increased at
rates in virtual agreement with those predicted from kinetic models.
They reached a mean of 143% CAPD steady state levels prior to the
weekly hemodialysis session during which they were readily reduced to
54%. Numerically integrated time average concentration was slightly
lower and total weekly clearance (liters) slightly higher than conven-
tional CAPD. Hemodialysis sessions were essentially isovolemic as
adequate fluid removal was obtained during PD. Electrolytes remained
normal. The protocol was well tolerated and was completely free of
complications. We conclude that this form of mixed mode therapy
warrants continued evaluation, both as an investigative tool and under
appropriate circumstances, as a possible new ESRD therapeutic mo-
dality.
Acute aluminium (Al) exposure due to contaminated hemodialysis
concentrate. C.J. Doecke, M.B. Fraenkel, L.J. Barratt, M. Cochran,
B.D. Rumbelow, Renal, Pharmacy & Biochemistry Departments, Flin-
ders Medical Centre, Bedford Park, South Australia. Aluminium accu-
mulation and the resultant toxicity is a major problem for patients with
severe renal impairment. Patients undergoing chronic hemodialysis
(HD) are known to be at particular risk. However, in recent years, the
use of reverse-osmosis treated water has resulted in reduced emphasis
being placed on dialysis fluids as the major source of aluminium
exposure. Recently, we noted a large rise in plasma Al level during a
HD treatment in 8 patients (average rise 7.5 smol/liter, range 3.2—11.2).
Hourly measurements in one patient during HD were: pre-4. I, I hr-7.6,
2 hr-9.5, 3 hr (post)-l0.4 smol/liter. Specific tests localized the problem
to a particular batch of commercial dialysis concentrate which was
found to have an Al concentration of 128 smol/liter. Other concentrates
used in the unit at the time had Al concentrations of 4.5, 1.3, 1.9 and 3.8
ismol/liter, respectively, values which conform to the recommendation
that levels in such fluids should not exceed 10 mollliter. Four patients
exposed to the contaminated concentrate for the maximum period of 3
months showed a rise in mean predialysis serum Al from 1.2 jmol/liter
pre-exposure to 5.4 smol/liter during exposure with a subsequent fall to
1.7 jmol/1iter 5 weeks after withdrawal of the contaminated batch. The
clinical significance of this exposure and recommendations to prevent a
similar problem in the future will be discussed.
Symptomatic benefit from cool diatysate? P.G. Kerr, C. van Bakel,
J.K. Dawborn, Renal Unit, Austin Hospital, Heidelberg, Victoria.
Symptoms were evaluated in 13 hemodialysis patients using dialysate of
progressively lower temperature. After a control period at 37°C (Stage
I) dialysate flow-rate was increased from 300 to 500 mllmin in half the
patients, but no change in temperature was made (Stage 2). In Stage 3
dialysate temperature was reduced to 36.5°C and in Stage 4 to 35°C
without any further change in dialysis conditions. All patients had their
blood pressure and temperature measured pre- and post-dialysis and
completed a questionnaire indicating if they experienced any of 9
specified symptoms: itch, restless legs, nausea, vomiting, headache,
cramp, lethargy, hypotension and change in temperature. Trial stages
were compared with chi-squared analysis using Yates correction.
Symptoms per dialysis fell from 1.11 to 0.71 between Stages 1 and 2 (P
< 0.005). This was considered to be a trial effect. There was further
improvement to 0.60 symptoms per dialysis when the temperature was
reduced to 36.5°C, and an increase in symptoms to 0,71 when the
temperature was reduced to 35°C due to the patients feeling cold. If this
symptom was eliminated there was a further reduction of symptoms at
35°C. Thus apart from feelings of temperature change, there was a
progressive reduction of symptoms from Stage I to Stage 4. Neither
dialysate flow-rate nor dialysate temperature significantly affected
either the patient's oral temperature or the change in blood pressure
during dialysis. Our results suggest there may be some benefit in
lowering the dialysate temperature but this is small in relation to the
placebo effect. Patients are unable to tolerate cold at a dialysate
temperature of 35°C. We recommend using a dialysate temperature of
36°C and have instituted this in our Unit.
Dialysis and transplantation in children—A 15 year experience. N.M.
Thomson, D.J. Lewis, M. Mclver, R. Atkins, D. Scott, Victorian
Paediatric dialysis/Transplantation Service, Monash Medical Centre,
Victoria, 3168, Australia. The treatment of end-stage renal failure(ESRF) in the child is associated with special problems, notably
nutrition, growth, education and social development. We have re-
viewed 38 children who have entered our ESRF program since 1972,
noting especially patient and renal allograft survival, dialysis experi-
ence, education, eventual employment and social adjustment. The
mean age of the children at ESRF was 12.4 years (range 4 to 17 years).
Renal disease was reflux (23), glomerulonephritis (10), Alport's syn-
drome (2), H.U.S. (I) dysplasia (1) cystinosis (1). Initial therapy was
peritoneal dialysis in 22 (CAPD 16), hemodialysis in 8, while 8 were
transplanted without initial dialysis. Patient survival was 97%, 86% and
80% at 1, 5 and 10 years, respectively. Fifty-two renal transplants have
been performed in 37 patients (cadaveric primary 28, secondary 10 and
tertiary I, living related 12 and cadaveric related (1). Primary cadaveric
graft survival was 72% at I year (90% since 1975). Mean time on dialysis
before transplantation was 5.0 months (range 0 to 15). Twenty patients
have been treated with CAPD for a mean period of 12.5 months (range
1—44). Hemodialysis has been performed in 21 patients for a mean
period of 26.5 months (range 1—160). Thirty-two patients are still living,
28 with functioning renal transplants and 4 on hemodialysis. Fourteen
patients are at school full-time (3 at special education schools), I is at
University, I I are working (2 University Graduates) and 6 are unem-
ployed. Four patients continue to have major growth retardation and 4
have poor social development. It is concluded that transplantation as
soon as possible after development of ESRF is the preferred treatment
and associated with excellent patient survival, and optimal growth,
education and social development.
